{
    "trace_id": "2b85c4cc-d0cf-46f2-8236-02685e6bfd04",
    "final_answer": "<solution>\n1. [‚úì] Clarify the biological goal and constraints based on user prompt  \n2. [‚úì] Define a conceptual CRISPR screen design (cell model, library, readout, conditions)  \n3. [‚úì] Identify pathways and gene classes most likely to regulate T cell exhaustion and TCR signaling  \n4. [‚úì] Propose a realistic CRISPR screening strategy (pooled vs arrayed; KO vs CRISPRi/a; controls)  \n5. [‚úì] Narrow down to a focused list of 32 high-priority genes predicted to maximally perturb TCR signaling differences between acute vs chronic stimulation  \n6. [‚úì] For each gene, briefly justify inclusion and expected direction of effect  \n7. [‚úì] Summarize how these 32-gene set would be used in a ‚Äúmini-screen‚Äù and how to interpret outcomes  \n\n---\n\nBelow I both (a) outline how you would design and interpret the screen, and (b) give a concrete, curated list of 32 genes with rationale.\n\n---\n\n## 1. Biological objective restated\n\nYou want to:\n\n- Perform a CRISPR screen in T cells  \n- Compare **TCR signaling output** under:\n  - **Acute condition:** IL‚Äë2 only (minimal TCR engagement; survival/proliferation cue)\n  - **Chronic condition:** anti‚ÄëCD3 + IL‚Äë2 (persistent TCR signaling ‚Üí exhaustion-like state)\n- Readout: A measure of **TCR signaling strength and/or exhaustion state** that changes between these two conditions (e.g., NFAT or NF‚ÄëŒ∫B reporter, CD69/PD‚Äë1/TOX expression, phospho‚ÄëZAP70/ERK, or functional cytokine output)\n- Design a focused library of **32 genes** whose perturbation (KO or CRISPRi/a) is expected to maximize the difference in TCR signaling between acute and chronic conditions (i.e., strongly modulate exhaustion).\n\nKey idea: choose genes that are:\n- Core exhaustion TFs and epigenetic regulators  \n- Coinhibitory receptors & proximal signaling nodes  \n- Cytokine pathway modulators that interact with IL‚Äë2 and chronic TCR signaling  \n- A few positive regulators to ‚Äúbreak‚Äù exhaustion and a few brakes to enforce it  \n\n---\n\n## 2. Conceptual CRISPR screen design\n\n### Cell model\n- **Primary human CD8+ T cells** from healthy donors, or an exhaustion-prone T‚Äëcell line (e.g., Jurkat with appropriate reporter) if feasibility is an issue.\n- Engineering:\n  - Lentiviral Cas9 or CRISPRi (dCas9-KRAB) line\n  - Introduce TCR signaling reporter (e.g., NFAT‚ÄëGFP, NF‚ÄëŒ∫B‚ÄëGFP, or IL‚Äë2 promoter‚ÄìGFP).\n\n### Stimulation conditions\n\n1. **Acute-like condition (‚ÄúIL‚Äë2 only‚Äù)**\n   - Cells cultured in IL‚Äë2 (e.g., 50‚Äì100 IU/mL) without continuous TCR engagement.\n   - ‚ÄúBaseline‚Äù TCR signaling low; IL‚Äë2R‚ÄìSTAT5 pathway active.\n\n2. **Chronic-like condition (‚Äúanti‚ÄëCD3 + IL‚Äë2‚Äù)**\n   - Plate-bound or bead-conjugated anti‚ÄëCD3 plus IL‚Äë2 for several days to weeks.\n   - Sustained TCR signal drives:\n     - PD‚Äë1, LAG‚Äë3, TIM‚Äë3, CTLA‚Äë4, TIGIT upregulation\n     - Transcriptional and epigenetic program: TOX, NR4A family, NFAT with low AP‚Äë1, BATF/IRF4 changes\n     - Decreased effector cytokines (IFN‚ÄëŒ≥, TNF) over time.\n\n### Readout options (to connect to CRISPR perturbations)\n\nExamples for a pooled screen:\n- **FACS‚Äëbased pooled screen**:\n  - Reporter: NFAT‚ÄëGFP or NF‚ÄëŒ∫B‚ÄëGFP.\n  - Sort high vs low GFP under each condition; sequence sgRNAs.\n  - Differential enrichment reflects genes that change the chronic vs acute ratio of reporter activity.\n\n- **Surface exhaustion markers**:\n  - Label PD‚Äë1, TIM‚Äë3, CD39, etc; sort high vs low PD‚Äë1 and sequence sgRNAs.\n\nFor a **32‚Äëgene mini-screen**, an arrayed format is feasible:\n- Transduce or electroporate 1‚Äì3 gRNAs per gene in 96‚Äëwell plates.\n- Measure:\n  - NFAT‚ÄëGFP MFI\n  - pZAP70 / pERK by phospho‚Äëflow\n  - PD‚Äë1, TOX, TIM‚Äë3 expression\n  - Cytokine production (IFN‚ÄëŒ≥, TNF, IL‚Äë2) by ELISA/ICS\n  - Compare readout between IL‚Äë2 only and anti‚ÄëCD3 + IL‚Äë2 for each perturbation.\n\n---\n\n## 3. Key biological modules to target\n\nTo maximize perturbation of exhaustion/TCR signaling balance:\n\n1. **Core exhaustion transcription factors / epigenetic architects**\n   - TOX/TOX2, NR4A family, BATF/IRF4, NFAT family, EOMES/T‚Äëbet, epigenetic writers/erasers.\n\n2. **Coinhibitory receptors & their adaptors**\n   - PDCD1, CTLA4, LAG3, HAVCR2, TIGIT, etc.\n   - SHP1/SHP2, CBL family ubiquitin ligases, CSK.\n\n3. **TCR proximal and co‚Äëstimulatory signaling**\n   - CD3‚ÄëITAM adaptor ZAP70, LCK, LAT, GRB2, SOS1, PLCG1, PI3K, AKT, mTOR.\n\n4. **Cytokine / survival pathway integration**\n   - JAK‚ÄëSTAT for IL‚Äë2 (JAK1, JAK3, STAT5A/B), common Œ≥ chain (IL2RG).\n   - Negative regulators of JAK‚ÄëSTAT (SOCS family, CISH, PTPN2).\n\n5. **Metabolic and stress signaling controlling exhaustion**\n   - mTORC1, AMPK (PRKAA1/2), HIF1A, VHL, PD‚Äë1‚ÄìPI3K axis.\n\nYou only have 32 slots, so the list balances:\n- Direct **exhaustion enforcers**\n- **Coinhibitory receptors** and their downstream phosphatases/ubiquitin ligases\n- **Positive TCR signaling components** (whose deletion collapses signaling and might ‚Äúablate‚Äù the difference)\n- **Integrators** of chronic TCR + IL‚Äë2 ‚Üí exhaustion.\n\n---\n\n## 4. Proposed 32‚Äëgene CRISPR mini‚Äëlibrary\n\nBelow is a curated list of 32 genes, grouped by function. For each, I note expected qualitative effect on chronic TCR signaling and/or exhaustion when **knocked out** in CD8 T cells.\n\n### A. Canonical exhaustion TFs and transcriptional regulators (10)\n\n1. **TOX**  \n   - Master regulator of CD8 T‚Äëcell exhaustion; enforces exhausted epigenetic and transcriptional state.\n   - KO: expected to *prevent or attenuate exhaustion*, preserve stronger TCR signaling and effector function under chronic stimulation.\n\n2. **TOX2**  \n   - Cooperates with TOX; contributes to exhaustion program.\n   - KO: similar but somewhat milder effect than TOX KO; enhances functional resilience to chronic stimulation.\n\n3. **NR4A1**  \n   - Orphan nuclear receptor induced by chronic TCR; promotes exhaustion and PD‚Äë1 expression.\n   - KO (alone or with NR4A2/3): reduces exhaustion markers, boosts effector function under chronic signaling.\n\n4. **NR4A2**  \n   - Redundant/overlapping with NR4A1/3 in exhaustion.\n   - KO: shifts balance away from tolerance/exhaustion, likely maintains higher NFAT/NF‚ÄëŒ∫B‚Äëdriven responses.\n\n5. **NR4A3**  \n   - Third NR4A family member; combined NR4A1/2/3 KO reported to dramatically reinvigorate T cells in chronic antigen settings.\n   - KO: strongly perturbs exhaustion phenotype.\n\n6. **BATF**  \n   - AP‚Äë1 family TF; contributes to chronic activation and exhaustion differentiation with IRF4.\n   - KO: expected to alter chronic TCR transcriptional output, potentially reducing exhaustion; may also impair effector differentiation (interesting bidirectional effect).\n\n7. **IRF4**  \n   - TCR signal strength sensor; high, sustained IRF4 promotes terminal exhaustion and effector programs in a dose‚Äëdependent manner.\n   - KO: reduces chronic TCR signal translation into exhaustion; also compromises effector function‚Äîhighly informative node.\n\n8. **NFATC1**  \n   - Major NFAT isoform in T cells; chronic NFAT activity without AP‚Äë1 drives exhaustion program.\n   - KO: reduces exhaustion induction but also reduces TCR‚Äëdriven transcription in general; will strongly affect NFAT‚Äëreporter readouts.\n\n9. **NFATC2**  \n   - Additional NFAT isoform; contributes to chronic TCR transcriptional response.\n   - KO: modulates NFAT signaling amplitude and exhaustion; combined with NFATC1 particularly powerful.\n\n10. **EOMES**  \n    - T‚Äëbox TF; high EOMES often seen in progenitor exhausted cells, balances with TBX21 (T‚Äëbet).\n    - KO: can skew differentiation toward T‚Äëbet‚Äìhigh effector vs terminal exhaustion; will likely shift functional response under chronic stimulation.\n\n---\n\n### B. Coinhibitory receptors and checkpoint molecules (8)\n\n11. **PDCD1 (PD‚Äë1)**  \n    - Canonical exhaustion marker and inhibitory receptor; recruits SHP2 to dampen TCR‚ÄëCD28‚ÄëPI3K signaling.\n    - KO: prevents PD‚Äë1‚Äìmediated inhibition; amplifies TCR signaling under chronic anti‚ÄëCD3 + IL‚Äë2, increasing reporter and cytokine output.\n\n12. **CTLA4**  \n    - Competes with CD28 for CD80/CD86; dampens co‚Äëstimulation.\n    - KO: enhances co‚Äëstimulation and likely TCR signaling; especially evident in chronic activation conditions.\n\n13. **LAG3**  \n    - Co‚Äëinhibitory receptor binding MHC‚ÄëII; associated with exhausted phenotype.\n    - KO: reduces inhibitory signaling; augments chronic TCR output and effector function.\n\n14. **HAVCR2 (TIM‚Äë3)**  \n    - Coinhibitory receptor linked to terminal exhaustion and dysfunctional T cells.\n    - KO: may preserve function in chronically stimulated cells, especially at late time points.\n\n15. **TIGIT**  \n    - Competes with CD226 for CD155/PVR; suppresses signaling via ITIM/ITSM motifs.\n    - KO: predicted to preserve more robust signaling and cytokine production under chronic stimulation.\n\n16. **CD244 (2B4)**  \n    - SLAM family receptor; can be activating or inhibitory, but in exhausted CD8 T cells tends toward inhibitory roles.\n    - KO: expected to enhance function and change chronic vs acute signaling relationship.\n\n17. **CD160**  \n    - Another coinhibitory receptor upregulated on chronically stimulated CD8 T cells.\n    - KO: reduces inhibitory tone, may increase chronic TCR signaling and effector function.\n\n18. **CD5**  \n    - Negative regulator of TCR signaling threshold; tunes TCR sensitivity.\n    - KO: lowers activation threshold, increases signaling amplitude under both acute and chronic conditions, potentially exaggerating chronic differences.\n\n---\n\n### C. Phosphatases, ubiquitin ligases, and proximal negative regulators (7)\n\n19. **PTPN11 (SHP2)**  \n    - Recruited by PD‚Äë1 and other ITIM/ITSM receptors; directly dephosphorylates TCR signaling components.\n    - KO: reduces checkpoint receptor inhibitory capacity, strongly enhances TCR signaling particularly in chronic condition.\n\n20. **PTPN6 (SHP1)**  \n    - Cytoplasmic phosphatase acting on multiple ITAM‚Äëassociated kinases and adaptors.\n    - KO: heightened TCR signaling; may sensitize cells to both acute and chronic stimulation; profound change in reporter readouts.\n\n21. **CSK**  \n    - Negative regulator of Src family kinases (e.g., LCK); phosphorylates inhibitory tyrosine residues.\n    - KO: hyperactivates LCK ‚Üí stronger TCR signaling, but may induce activation‚Äëinduced cell death under chronic stimulation; very strong perturbation.\n\n22. **CBLB**  \n    - E3 ubiquitin ligase; negative regulator of TCR and co‚Äëstimulatory signals.\n    - KO: sustains signaling and proliferation under suboptimal stimulation; expected to strongly alter chronic vs acute TCR responses.\n\n23. **ITCH**  \n    - HECT E3 ligase; regulates signaling adaptors and transcription factors downstream of TCR.\n    - KO: may stabilize positive signaling components; increases TCR signaling under chronic conditions.\n\n24. **SOCS1**  \n    - Negative regulator of cytokine receptor JAK‚ÄëSTAT (including IL‚Äë2R); also influences TCR‚Äëdriven responses indirectly.\n    - KO: increases IL‚Äë2‚ÄìSTAT5 signaling, potentially counters exhaustion by supporting survival/proliferation under chronic TCR.\n\n25. **CISH**  \n    - SOCS family member (Cytokine Inducible SH2‚Äëcontaining protein); directly inhibits IL‚Äë2 and IL‚Äë15 signaling.\n    - KO: enhances IL‚Äë2 responsiveness; in chronic stimulation this may preserve functional competence, increasing differential signaling.\n\n---\n\n### D. TCR and IL‚Äë2 pathway core signaling nodes (7)\n\n26. **LCP2 (SLP‚Äë76)**  \n    - Central adaptor in TCR signaling (LAT‚ÄìSLP‚Äë76 signalosome).\n    - KO: dramatically reduces TCR signaling (NFAT/NF‚ÄëŒ∫B), essentially abrogates response to anti‚ÄëCD3; minimal difference between acute and chronic because signaling collapses‚Äîimportant negative control for TCR dependency and maximum suppression.\n\n27. **LAT**  \n    - Membrane adaptor that recruits GRB2, GADS, PLCŒ≥1, etc.\n    - KO: similar to LCP2 loss; near‚Äëcomplete shutdown of TCR proximal signaling; provides maximal ‚Äúon‚Äëpathway loss-of-function‚Äù reference.\n\n28. **PLCG1**  \n    - PLCŒ≥1; generates IP3/DAG downstream of LAT, essential for Ca¬≤‚Å∫ flux ‚Üí NFAT activation.\n    - KO: strongly decreases NFAT and NF‚ÄëŒ∫B activation; great for mapping the dependence of your TCR reporter on the canonical pathway.\n\n29. **PIK3CD (p110Œ¥)**  \n    - Catalytic subunit of PI3KŒ¥; dominant in T cells; controls AKT‚ÄìmTOR downstream of TCR/CD28.\n    - KO: blunts PI3K‚ÄìAKT‚ÄìmTOR; can reduce effector differentiation and affect exhaustion; strong perturbation in chronic condition.\n\n30. **AKT1**  \n    - Central kinase downstream of PI3K; integrates TCR/CD28 and cytokine signals.\n    - KO: impairs survival, metabolism, and effector functions; may promote memory-like features and modulate exhaustion phenotype under chronic TCR + IL‚Äë2.\n\n31. **IL2RG (common Œ≥ chain)**  \n    - Shared component of IL‚Äë2, IL‚Äë7, IL‚Äë15, etc. receptors.\n    - KO: abrogates IL‚Äë2 signaling in both conditions; serves as a maximal perturbation for IL‚Äë2 dependence, clarifies interplay between cytokine and TCR inputs.\n\n32. **STAT5B**  \n    - Key transcription factor downstream of IL‚Äë2R.\n    - KO: diminishes IL‚Äë2 signaling; alters survival/proliferation balance, likely affecting how chronic TCR drives exhaustion vs deletion; highly informative IL‚Äë2‚Äëaxis perturbation.\n\n---\n\n## 5. How these 32 genes maximize perturbation of the phenotype\n\nThis set is crafted to create **large, interpretable shifts** in TCR signaling outputs:\n\n- **Direct exhaustion enforcers (TOX, TOX2, NR4A1/2/3, BATF, IRF4, NFATC1/2, EOMES)**  \n  ‚Üí Their KO should *block or reshape* the exhaustion program, resulting in:\n  - Higher NFAT/NF‚ÄëŒ∫B reporter signal\n  - Lower PD‚Äë1/TIM‚Äë3/TOX expression\n  - Sustained cytokine output in chronic anti‚ÄëCD3 + IL‚Äë2 vs control.\n\n- **Checkpoint receptors & proximal inhibitory machinery (PDCD1, CTLA4, LAG3, HAVCR2, TIGIT, CD244, CD160, CD5, PTPN11, PTPN6, CSK, CBLB, ITCH, SOCS1, CISH)**  \n  ‚Üí Their KO removes **brakes on signaling**, especially evident under chronic stimulation where these brakes are normally engaged. You expect:\n  - Increased TCR signaling amplitude in chronic vs acute\n  - Altered shape of dose‚Äìresponse curves to anti‚ÄëCD3\n  - Possible rescue of function in otherwise exhausted cells.\n\n- **Core TCR/IL‚Äë2 signalosome components (LCP2, LAT, PLCG1, PIK3CD, AKT1, IL2RG, STAT5B)**  \n  ‚Üí Their KO effectively **rewires the input‚Äìoutput relationship**:\n  - Some (LCP2, LAT, PLCG1) collapse TCR signaling: minimal reporter change even under strong anti‚ÄëCD3.\n  - Others (PIK3CD, AKT1) preferentially tune metabolic and survival arms that are critical for chronic responses.\n  - IL2RG and STAT5B mutations decouple IL‚Äë2 effects, revealing which aspects of exhaustion depend on IL‚Äë2‚ÄìSTAT5 vs TCR‚ÄìNFAT.\n\nTogether, you end up with a **diverse, mechanistically rich set of perturbations** that will:\n- Produce large dynamic range in TCR signaling measures.\n- Differentiate modules that regulate **acute activation** vs **chronic exhaustion**.\n- Provide strong positive and negative controls for both TCR and IL‚Äë2 axes.\n\n---\n\n## 6. Practical ‚Äúmini‚Äëscreen‚Äù usage\n\nTo ‚Äúexperience‚Äù the screen with this 32‚Äëgene panel:\n\n1. **Library design**\n   - 3‚Äì4 gRNAs per gene (96‚Äì128 guides total) + 8‚Äì16 non‚Äëtargeting controls and 4‚Äì8 essential gene controls (e.g., RPA3) for QC.\n   - Use SpCas9 KO in primary CD8 T cells or Jurkat + NFAT‚ÄëGFP.\n\n2. **Transduction and selection**\n   - MOI ~0.3 to favor single integration.\n   - Puromycin/blasticidin selection to enrich sgRNA‚Äëpositive cells.\n   - Maintain enough cells for ~500‚Äì1,000√ó coverage per sgRNA if pooled.\n\n3. **Stimulation and readout**\n   - Split cells into:\n     - IL‚Äë2‚Äëonly arm\n     - Anti‚ÄëCD3 + IL‚Äë2 arm (sustained stimulation)\n   - After defined timepoints (e.g., day 3, 7, 14), measure:\n     - NFAT‚ÄëGFP / NF‚ÄëŒ∫B‚ÄëGFP MFI (flow)\n     - PD‚Äë1, TOX, TIM‚Äë3 surface/intracellular staining\n     - Cytokines (IFN‚ÄëŒ≥, TNF, IL‚Äë2) by ELISA/ICS.\n\n4. **Analysis**\n   - For each gene, compute:\n     - ŒîTCR_signal = (chronic condition readout ‚Äì acute condition readout) for KO vs control.\n   - Genes with largest deviation in ŒîTCR_signal (positive or negative) are top regulators of exhaustion vs sustained function.\n\n5. **Follow‚Äëup**\n   - Deep phenotyping (transcriptomics, ATAC‚Äëseq) of the most extreme hits (e.g., TOX‚ÄëKO, NR4A‚Äëtriple KO, PDCD1‚ÄëKO, PTPN11‚ÄëKO, LCP2‚ÄëKO) to delineate pathways.\n\n---\n\nIf you‚Äôd like, I can next:\n- Suggest specific CRISPR sgRNA design strategy for these 32 targets (using the sgRNA Design Guide and CRISPick approach in your environment).\n- Propose concrete readouts (antibody panels, reporter constructs) and a basic analysis pipeline (including statistical comparisons for an arrayed 96‚Äëwell mini‚Äëscreen).  \n</solution>",
    "messages": [
        {
            "id": null,
            "name": null,
            "type": "system",
            "content": "\nYou are Aigen R0, helpful biomedical assistant assigned with the task of problem-solving.\nTo achieve this, you will be using an interactive coding environment equipped with a variety of tool functions, data, and softwares to assist you throughout the process.\n\nGiven a task, make a plan first. The plan should be a numbered list of steps that you will take to solve the task. Be specific and detailed.\nFormat your plan as a checklist with empty checkboxes like this:\n1. [ ] First step\n2. [ ] Second step\n3. [ ] Third step\n\nFollow the plan step by step. After completing each step, update the checklist by replacing the empty checkbox with a checkmark:\n1. [‚úì] First step (completed)\n2. [ ] Second step\n3. [ ] Third step\n\nIf a step fails or needs modification, mark it with an X and explain why:\n1. [‚úì] First step (completed)\n2. [‚úó] Second step (failed because...)\n3. [ ] Modified second step\n4. [ ] Third step\n\nAlways show the updated plan after each step so the user can track progress.\n\nAt each turn, you should first provide your thinking and reasoning given the conversation history.\nAfter that, you have two options:\n\n1) Interact with a programming environment and receive the corresponding output within <observe></observe>. Your code should be enclosed using \"<execute>\" tag, for example: <execute> print(\"Hello World!\") </execute>. IMPORTANT: You must end the code block with </execute> tag.\n   - For Python code (default): <execute> print(\"Hello World!\") </execute>\n   - For R code: <execute> #!R\nlibrary(ggplot2)\nprint(\"Hello from R\") </execute>\n   - For Bash scripts and commands: <execute> #!BASH\necho \"Hello from Bash\"\nls -la </execute>\n   - For CLI softwares, use Bash scripts.\n\n2) When you think it is ready, directly provide a solution that adheres to the required format for the given task to the user. Your solution should be enclosed using \"<solution>\" tag, for example: The answer is <solution> A </solution>. IMPORTANT: You must end the solution block with </solution> tag.\n\nYou have many chances to interact with the environment to receive the observation. So you can decompose your code into multiple steps.\nDon't overcomplicate the code. Keep it simple and easy to understand.\nWhen writing the code, please print out the steps and results in a clear and concise manner, like a research log.\nWhen calling the existing python functions in the function dictionary, YOU MUST SAVE THE OUTPUT and PRINT OUT the result.\nFor example, result = understand_scRNA(XXX) print(result)\nOtherwise the system will not be able to know what has been done.\n\nFor R code, use the #!R marker at the beginning of your code block to indicate it's R code.\nFor Bash scripts and commands, use the #!BASH marker at the beginning of your code block. This allows for both simple commands and multi-line scripts with variables, loops, conditionals, loops, and other Bash features.\n\nIn each response, you must include EITHER <execute> or <solution> tag. Not both at the same time. Do not respond with messages without any tags. No empty messages.\n\nPROTOCOL GENERATION:\nIf the user requests an experimental protocol, use search_protocols(), advanced_web_search_claude(), list_local_protocols(), and read_local_protocol() to generate an accurate protocol. Include details such as reagents (with catalog numbers if available), equipment specifications, replicate requirements, error handling, and troubleshooting - but ONLY include information found in these resources. Do not make up specifications, catalog numbers, or equipment details. Prioritize accuracy over completeness.\n\n\nPRIORITY CUSTOM RESOURCES\n===============================\nIMPORTANT: The following custom resources have been specifically added for your use.\n    PRIORITIZE using these resources as they are directly relevant to your task.\n    Always consider these FIRST and in the meantime using default resources.\n\n\nüìö KNOW-HOW DOCUMENTS (BEST PRACTICES & PROTOCOLS - ALREADY LOADED):\nüìö sgRNA Design Guide: Three-Tiered Approach:\n# sgRNA Design Guide: Three-Tiered Approach\n\n## Citations and Acknowledgments\n\n### If you use validated sgRNAs from our database (Option 1):\n- **Database Source**: Addgene (https://www.addgene.org)\n- **Citation**: Always cite the original publication associated with each sgRNA using the PubMed ID provided in the database\n- **Acknowledgment**: \"Validated sgRNA sequences obtained from Addgene (https://www.addgene.org/crispr/reference/grna-sequence/)\"\n\n### If you use CRISPick designs (Option 2):\n- **Acknowledgment Statement**: \"Guide designs provided by the CRISPick web tool of the GPP at the Broad Institute\"\n- **Citation for Cas9 designs (SpCas9, SaCas9)**: Sanson KR, et al. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nat Commun. 2018;9(1):5416. PMID: 30575746\n- **Citation for Cas12a designs (AsCas12a, enAsCas12a)**: DeWeirdt PC, et al. Optimization of AsCas12a for combinatorial genetic screens in human cells. Nat Biotechnol. 2021;39(1):94-104. PMID: 32661438\n  - Note: This paper describes enAsCas12a optimization; specify which variant you used in your methods\n\n## Overview\n\nThis guide provides a three-tiered approach to sgRNA design, prioritizing validated sequences before moving to computational predictions. Always start with Option 1 and proceed to subsequent options only if needed.\n\n\n## Option 1: Search Validated sgRNA Sequences (Recommended First)\n\n### 1.1 Search for Validated sgRNAs\n\n**IMPORTANT**: You MUST complete BOTH Method 1 AND Method 2 before proceeding to Option 2. Do not skip Method 2 even if Method 1 finds no results.\n\n#### Method 1: Search Our Database (Fastest)\n\nWe maintain a curated database of 300+ validated sgRNA sequences from Addgene with experimental evidence.\n\n**Location**: `biomni/know_how/resource/addgene_grna_sequences.csv`\n\n**Search the database**:\n```python\nimport pandas as pd\n\n# Load the database\ndf = pd.read_csv('addgene_grna_sequences.csv')\n\n# Search for your gene\ngene_name = \"TP53\"\nresults = df[df['Target_Gene'].str.upper() == gene_name.upper()]\n\n# Filter by species and application\nresults_filtered = results[\n    (results['Target_Species'] == 'H. sapiens') &\n    (results['Application'] == 'cut')  # or 'activate', 'RNA targeting'\n]\n\n# Display results with references\nprint(results_filtered[['Target_Gene', 'Target_Sequence',\n                        'Plasmid_ID', 'PubMed_ID', 'Depositor']])\n```\n\n**Database columns**:\n- `Target_Gene`: Gene symbol\n- `Target_Species`: Organism (H. sapiens, M. musculus, etc.)\n- `Target_Sequence`: 20bp sgRNA sequence (5' to 3')\n- `Application`: cut (knockout), activate (CRISPRa), RNA targeting (CRISPRi)\n- `Cas9_Species`: S. pyogenes, S. aureus, etc.\n- `Plasmid_ID`: Addgene plasmid number\n- `Plasmid_URL`: Direct link to plasmid page\n- `PubMed_ID`: **Publication reference** (cite this in your work)\n- `PubMed_URL`: Direct link to paper\n- `Depositor`: Research lab that contributed the sequence\n\n#### Method 2: Advanced Web Search (REQUIRED - Do Not Skip)\n\n**CRITICAL**: Even if Method 1 found no results, you MUST perform this literature search before moving to Option 2. Many validated sgRNAs are published in literature but not in the Addgene database.\n\nUse `advanced_web_search_claude` from `biomni.tool.literature` to find validated sgRNAs from literature and databases:\n\n```python\nfrom biomni.tool.literature import advanced_web_search_claude\n\n# Example usage\nresults = advanced_web_search_claude(\"sgRNA TP53 validated H. sapiens experimental\")\n```\n\n**Search queries to try (use multiple):**\n```\n\"sgRNA\" OR \"guide RNA\" \"[GENE_NAME]\" validated experimental\n\"CRISPR knockout\" \"[GENE_NAME]\" sgRNA sequence validated\n\"[GENE_NAME]\" sgRNA \"cutting efficiency\" OR \"on-target\"\n\"[GENE_NAME]\" \"guide sequence\" CRISPR validated\n```\n\n**Example for TP53:**\n```\n\"sgRNA\" \"TP53\" validated \"H. sapiens\" experimental\n\"CRISPR knockout\" \"TP53\" guide sequence validated\n```\n\n**What to search for in results:**\n- Published papers with validated sgRNA sequences\n- Supplementary materials containing sgRNA sequences\n- Other CRISPR databases (e.g., GenScript, Horizon Discovery)\n- Laboratory protocols with specific sgRNA sequences\n\n**IMPORTANT**: Spend adequate time searching literature. Look through at least the first 10-15 search results and check supplementary materials of relevant papers.\n\n#### What to Do with Results:\n\n‚úÖ **If you find matching sgRNAs (from either method):**\n1. **Record the sgRNA sequence** (20bp target sequence)\n2. **Note the reference**:\n   - From database: Use `PubMed_ID` to cite the original paper\n   - From web search: Record the publication DOI/PubMed ID\n3. **Record validation details**: Cell line, cutting efficiency, any reported off-targets\n\n\n**Example result format:**\n```\nGene: TP53\nsgRNA sequence: GAGGTTGTGAGGCGCTGCCC\nSpecies: H. sapiens (human)\nApplication: Knockout (cut)\nReference: PubMed ID 24336569 (Ran et al., 2013)\nValidation: Tested in HEK293T cells, 85% cutting efficiency\n```\n\n‚ùå **If no matches found in BOTH Method 1 AND Method 2:**\nOnly then proceed to **Option 2: Download CRISPick Dataset**\n\n\n## Option 2: Download Pre-Computed sgRNAs from CRISPick\n\n### When to Use This Option?\n- No validated sgRNAs found in Addgene\n- Need comprehensive coverage of a gene\n- Want multiple sgRNA options with predicted scores\n- Working with genome-scale screening\n\n### 2.1 Overview of CRISPick\n\n**CRISPick** (from Broad Institute GPP) provides pre-computed sgRNA designs for entire genomes with 238 available datasets covering:\n- Human (GRCh38, GRCh37)\n- Mouse (GRCm38, GRCm39)\n- Dog, Cow, Monkey, and other model organisms\n- Multiple Cas enzymes (SpCas9, SaCas9, AsCas12a, enAsCas12a)\n  - **IMPORTANT**: AsCas12a and enAsCas12a are DIFFERENT enzymes\n  - **AsCas12a**: Wild-type Acidaminococcus sp. Cas12a\n  - **enAsCas12a**: Enhanced variant with improved activity\n  - **Critical**: sgRNAs designed for enAsCas12a may NOT work with wild-type AsCas12a\n  - Always match the dataset to your specific Cas12a variant\n- Different applications (knockout, activation, inhibition)\n\n### 2.2 Find the Download Link\n\n**All 238 download links are available in**: `biomni/know_how/resource/CRISPick_download_links.txt`\n\n#### Step 1: Understand File Naming Convention\n\nFiles are named: `sgRNA_design_{TAXID}_{GENOME}_{CAS}_{APPLICATION}_{ALGORITHM}_{SOURCE}_{DATE}.txt.gz`\n\n**Common datasets:**\n\n| Organism | Genome | Cas9 | Application | Search Pattern |\n|-|--||-|-|\n| Human | GRCh38 | SpCas9 | Knockout | `9606_GRCh38_SpyoCas9_CRISPRko` |\n| Human | GRCh38 | SpCas9 | Activation | `9606_GRCh38_SpyoCas9_CRISPRa` |\n| Human | GRCh38 | SaCas9 | Knockout | `9606_GRCh38_SaurCas9_CRISPRko` |\n| Mouse | GRCm38 | SpCas9 | Knockout | `10090_GRCm38_SpyoCas9_CRISPRko` |\n| Mouse | GRCm38 | SpCas9 | Activation | `10090_GRCm38_SpyoCas9_CRISPRa` |\n\n**Key components:**\n- **TAXID**: `9606` (Human), `10090` (Mouse), `9615` (Dog), `9913` (Cow)\n- **CAS**:\n  - `SpyoCas9` (SpCas9, NGG PAM)\n  - `SaurCas9` (SaCas9, NNGRRT PAM)\n  - `AsCas12a` (Wild-type Cas12a, TTTV PAM)\n  - `enAsCas12a` (Enhanced Cas12a, TTTV PAM)\n  - **WARNING**: Do NOT use AsCas12a datasets if you have enAsCas12a, and vice versa\n- **APPLICATION**: `CRISPRko` (knockout), `CRISPRa` (activation), `CRISPRi` (inhibition)\n\n#### Step 2: Find Your Download URL\n\n```bash\n# Search the download links file\ngrep \"9606_GRCh38_SpyoCas9_CRISPRko\" biomni/know_how/resource/CRISPick_download_links.txt\n\n# Or for mouse\ngrep \"10090_GRCm38_SpyoCas9_CRISPRko\" biomni/know_how/resource/CRISPick_download_links.txt\n```\n\n#### Step 3: Download and Extract\n\n```bash\n# Copy the URL from download_links.txt, then:\nwget [PASTE_URL_HERE]\n\n# Extract the file\ngunzip sgRNA_design_*.txt.gz\n```\n\n**File sizes**: Knockout (300-700 MB), Activation (50-100 MB), Summary files (1-3 MB)\n\n### 2.4 Understanding the File Format\n\nThe `.txt` file is tab-delimited. Column names differ between knockout and activation/inhibition datasets.\n\n**Essential Columns (All files):**\n- **sgRNA Sequence**: The 20bp guide RNA sequence (5' to 3')\n- **Target Gene Symbol**: Gene name (e.g., \"TP53\", \"BRCA1\")\n- **Combined Rank**: Overall ranking (lower = better) - **Use this by default**\n- **On-Target Rank**: Ranking by efficiency only (lower = better)\n- **Off-Target Rank**: Ranking by specificity only (lower = better)\n- **PAM Sequence**: The PAM sequence (e.g., \"AGG\", \"TGG\")\n\n**Knockout-specific columns:**\n- **sgRNA Cut Position (1-based)**: Genomic coordinate of cut site\n- **Exon Number**: Which exon is targeted\n- **Target Cut %**: Percentage of protein affected\n\n**Activation/Inhibition-specific columns:**\n- **sgRNA 'Cut' Position**: Position relative to gene\n- **sgRNA 'Cut' Site TSS Offset**: Distance from transcription start site (bp)\n- **DHS Score**: DNase hypersensitivity score (for CRISPRa)\n\n### 2.5 Extract and Select sgRNAs\n\n#### Step 1: Load Data and Filter for Your Gene\n\n```python\nimport pandas as pd\n\n# Load the dataset\ndf = pd.read_csv('sgRNA_design_9606_GRCh38_SpyoCas9_CRISPRko_*.txt',\n                 sep='\\t', low_memory=False)\n\n# Filter for your gene\ngene_name = \"TP53\"\ngene_sgrnas = df[df['Target Gene Symbol'] == gene_name].copy()\n\nprint(f\"Found {len(gene_sgrnas)} sgRNAs for {gene_name}\")\n```\n\n#### Step 2: Select Top sgRNAs\n\n**Default: Use Combined Rank (balances efficiency and specificity)**\n```python\n# Sort by Combined Rank (lower is better)\ntop_sgrnas = gene_sgrnas.nsmallest(10, 'Combined Rank')\n\nprint(top_sgrnas[['sgRNA Sequence', 'Combined Rank',\n                   'Exon Number', 'sgRNA Cut Position (1-based)']])\n```\n\n**Option A: Prioritize On-Target Efficiency**\n```python\n# Sort by On-Target Rank (for maximum cutting efficiency)\nefficient_sgrnas = gene_sgrnas.nsmallest(10, 'On-Target Rank')\n```\n\n**Option B: Prioritize Off-Target Specificity**\n```python\n# Sort by Off-Target Rank (for maximum specificity)\nspecific_sgrnas = gene_sgrnas.nsmallest(10, 'Off-Target Rank')\n```\n\n#### Step 3: Filter by Custom Criteria (Optional)\n\n**Filter by Exon Number:**\n```python\n# Target specific exon (e.g., exon 5)\nexon5_sgrnas = gene_sgrnas[gene_sgrnas['Exon Number'] == 5]\ntop_exon5 = exon5_sgrnas.nsmallest(5, 'Combined Rank')\n```\n\n**Filter by Genomic Position:**\n```python\n# Target specific genomic range\nposition_filtered = gene_sgrnas[\n    (gene_sgrnas['sgRNA Cut Position (1-based)'] >= 7572000) &\n    (gene_sgrnas['sgRNA Cut Position (1-based)'] <= 7575000)\n]\n```\n\n**Target Early Exons for Knockout:**\n```python\n# Get sgRNAs from first 3 exons\nearly_exons = gene_sgrnas[gene_sgrnas['Exon Number'] <= 3]\ntop_early = early_exons.nsmallest(10, 'Combined Rank')\n```\n\n**Filter by Target Cut Percentage:**\n```python\n# Target sgRNAs that affect significant portion of protein\nhigh_impact = gene_sgrnas[gene_sgrnas['Target Cut %'] <= 50]  # Cut in first 50%\ntop_high_impact = high_impact.nsmallest(10, 'Combined Rank')\n```\n\n#### Step 4: Select Multiple sgRNAs for Validation\n\n```python\n# Get top 4 sgRNAs from different exons for redundancy\nfinal_selection = gene_sgrnas.sort_values('Combined Rank').groupby('Exon Number').head(1).head(4)\n\n# Save results\nfinal_selection.to_csv(f'{gene_name}_selected_sgRNAs.csv', index=False)\n\nprint(\"\\nSelected sgRNAs:\")\nprint(final_selection[['sgRNA Sequence', 'Exon Number', 'Combined Rank']])\n```\n\n### 2.6 What to Do with Results\n\n‚úÖ **Once you have selected sgRNAs:**\n1. Choose **3-4 sgRNAs** (use Combined_Rank by default)\n\n‚ùå **If dataset doesn't cover your gene or organism:**\nProceed to **Option 3: De Novo sgRNA Design**\n\n\n## Option 3: General sgRNA Design Guidelines (Last Resort)\n\n### When to Use This Option?\n- Gene not covered in CRISPick datasets\n- Non-model organism\n- Custom design requirements\n\n### General Design Rules\n\n#### Essential Requirements:\n1. **Length**:\n   - 20 bp for SpCas9 and SaCas9\n   - 23-25 bp for Cas12a variants (AsCas12a, enAsCas12a)\n2. **PAM sequence**:\n   - **SpCas9**: Requires **NGG** immediately after target (3' end)\n   - **SaCas9**: Requires **NNGRRT** immediately after target (3' end)\n   - **AsCas12a** (wild-type): Requires **TTTV** before target (5' end)\n   - **enAsCas12a** (enhanced): Requires **TTTV** before target (5' end)\n   - **CRITICAL**: Guides designed for enAsCas12a may not work with wild-type AsCas12a due to different activity profiles\n3. **GC content**: 40-60% is optimal\n4. **Avoid**:\n   - TTTT sequences (terminates transcription)\n   - Long runs of same nucleotide (>4 repeats)\n\n#### Target Location:\n- **For knockout**: Target early exons (first 50% of gene)\n- **For activation**: Target -200 to +1 bp from transcription start site (TSS)\n- **For inhibition**: Target -50 to +300 bp from TSS\n\n#### Best Practices:\n- **Test 3-4 different sgRNAs** per target gene\n- Select sgRNAs with high efficiency scores (>0.5) and minimal off-targets\n- Validate experimentally with Sanger sequencing\n\n\n## Quick Start Examples\n\n### Example 1: Knockout TP53 in Human Cells\n\n**Step 1**: Check Addgene\n```python\ndf = pd.read_csv('addgene_grna_sequences.csv')\ntp53_results = df[(df['Target_Gene'] == 'TP53') &\n                  (df['Target_Species'] == 'H. sapiens') &\n                  (df['Application'] == 'cut')]\n# Result: Found 0 entries ‚Üí Proceed to Option 2\n```\n\n**Step 2**: Download CRISPick dataset\n```bash\n# Download human GRCh38 SpCas9 knockout dataset\nwget https://portals.broadinstitute.org/gppx/public/sgrna_design/api/downloads/\\\nsgRNA_design_9606_GRCh38_SpyoCas9_CRISPRko_RS3seq-Chen2013+RS3target_NCBI_20241104.txt.gz\n\ngunzip sgRNA_design_9606_GRCh38_SpyoCas9_CRISPRko_*.txt.gz\n```\n\n**Step 3**: Extract TP53 sgRNAs\n```python\ndf = pd.read_csv('sgRNA_design_9606_GRCh38_SpyoCas9_CRISPRko_*.txt', sep='\\t')\ntp53 = df[df['Gene_Symbol'] == 'TP53']\ntop_sgrnas = tp53[\n    (tp53['sgRNA_score'] > 0.6) &\n    (tp53['Off_target_stringency'] > 0.5)\n].sort_values('sgRNA_score', ascending=False).head(4)\n\nprint(top_sgrnas[['sgRNA_sequence', 'sgRNA_score', 'Exon_ID']])\n```\n\n### Example 2: Activate OCT4 in Human iPSCs\n\n**Step 1**: Check Addgene\n```python\noct4_results = df[(df['Target_Gene'] == 'OCT4') &\n                  (df['Application'] == 'activate')]\n# Found 1 validated sgRNA!\nprint(oct4_results['Target_Sequence'].values[0])\n# Use this sequence ‚úÖ\n```\n\n\n**Remember**: Always start with validated sequences (Option 1), then move to pre-computed designs (Option 2), and only use de novo design (Option 3) when necessary. Testing 3-4 sgRNAs per gene is standard practice regardless of prediction scores.\n\nIMPORTANT: These documents are ALREADY AVAILABLE in your context. You do NOT need to\nretrieve them or \"review\" them as a separate step. You can DIRECTLY reference and use\nthe information from these documents to answer questions, provide protocols, suggest\nparameters, and offer troubleshooting guidance.\n\nThese documents contain expert knowledge, protocols, and troubleshooting guidance.\nReference them directly for experimental design, methodology, and problem-solving.\n\n===============================\n\n\nEnvironment Resources:\n\n- Function Dictionary:\nBased on your query, I've identified the following most relevant functions that you can use in your code:\n---\nImport file: biomni.tool.literature\n===================================\nMethod: fetch_supplementary_info_from_doi\n  Description: Fetches supplementary information for a paper given its DOI and saves it to a specified directory.\n  Required Parameters:\n    - doi (str): The paper DOI [Default: None]\n  Optional Parameters:\n    - output_dir (str): Directory to save supplementary files [Default: supplementary_info]\n\nMethod: query_arxiv\n  Description: Query arXiv for papers based on the provided search query.\n  Required Parameters:\n    - query (str): The search query string. [Default: None]\n  Optional Parameters:\n    - max_papers (int): The maximum number of papers to retrieve. [Default: 10]\n\nMethod: query_scholar\n  Description: Query Google Scholar for papers based on the provided search query and return the first search result.\n  Required Parameters:\n    - query (str): The search query string. [Default: None]\n\nMethod: query_pubmed\n  Description: Query PubMed for papers based on the provided search query.\n  Required Parameters:\n    - query (str): The search query string. [Default: None]\n  Optional Parameters:\n    - max_papers (int): The maximum number of papers to retrieve. [Default: 10]\n    - max_retries (int): Maximum number of retry attempts with modified queries. [Default: 3]\n\nMethod: search_google\n  Description: Search using Google search and return formatted results.\n  Required Parameters:\n    - query (str): The search query (e.g., \"protocol text or search question\") [Default: None]\n  Optional Parameters:\n    - num_results (int): Number of results to return [Default: 3]\n    - language (str): Language code for search results [Default: en]\n\nMethod: extract_url_content\n  Description: Extract the text content of a webpage using requests and BeautifulSoup.\n  Required Parameters:\n    - url (str): Webpage URL to extract content from [Default: None]\n\nMethod: extract_pdf_content\n  Description: Extract text content from a PDF file.\n  Required Parameters:\n    - url (str): URL of the PDF file [Default: None]\n\nMethod: advanced_web_search_claude\n  Description: Initiate an advanced web search by launching a specialized agent to collect relevant information and citations through multiple rounds of web searches for a given query.\n  Required Parameters:\n    - query (str): The search query string. [Default: None]\n  Optional Parameters:\n    - max_searches (int): Maximum number of searches [Default: 1]\n    - max_retries (int): Maximum number of retry attempts with modified queries. [Default: 3]\n\n\nImport file: biomni.tool.bioengineering\n=======================================\nMethod: perform_crispr_cas9_genome_editing\n  Description: Simulates CRISPR-Cas9 genome editing process including guide RNA design, delivery, and analysis.\n  Required Parameters:\n    - guide_rna_sequences (List[str]): List of guide RNA sequences (20 nucleotides each) targeting the genomic region of interest [Default: None]\n    - target_genomic_loci (str): Target genomic sequence to be edited (should be longer than guide RNA and contain the target sites) [Default: None]\n    - cell_tissue_type (str): Type of cell or tissue being edited (affects delivery efficiency and editing outcomes) [Default: None]\n\n\nImport file: biomni.tool.cell_biology\n=====================================\nMethod: perform_facs_cell_sorting\n  Description: Performs Fluorescence-Activated Cell Sorting (FACS) to enrich cell populations based on fluorescence characteristics.\n  Required Parameters:\n    - cell_suspension_data (str): Path to the FCS file containing flow cytometry data [Default: None]\n    - fluorescence_parameter (str): The fluorescence parameter to use for sorting (e.g., 'GFP', 'FITC', 'PE') [Default: None]\n  Optional Parameters:\n    - threshold_min (float): Minimum threshold for the fluorescence parameter. Cells below this value will be excluded [Default: None]\n    - threshold_max (float): Maximum threshold for the fluorescence parameter. Cells above this value will be excluded [Default: None]\n    - output_file (str): Filename to save the sorted cell population data [Default: sorted_cells.csv]\n\n\nImport file: biomni.tool.molecular_biology\n==========================================\nMethod: align_sequences\n  Description: Align short sequences (primers) to a longer sequence, allowing for one mismatch. Checks both forward and reverse complement strands.\n  Required Parameters:\n    - long_seq (str): Target DNA sequence [Default: None]\n    - short_seqs (Union[str, List[str]]): Single primer or list of primers [Default: None]\n\nMethod: design_knockout_sgrna\n  Description: Design sgRNAs for CRISPR knockout by searching pre-computed sgRNA libraries. Returns optimized guide RNAs for targeting a specific gene.\n  Required Parameters:\n    - gene_name (str): Target gene symbol/name (e.g., \"EGFR\", \"TP53\") [Default: None]\n    - data_lake_path (str): Path to the data lake [Default: None]\n  Optional Parameters:\n    - species (str): Target organism species [Default: human]\n    - num_guides (int): Number of guides to return [Default: 1]\n\n\nImport file: biomni.tool.genetics\n=================================\nMethod: analyze_cas9_mutation_outcomes\n  Description: Analyzes and categorizes mutations induced by Cas9 at target sites.\n  Required Parameters:\n    - reference_sequences (dict): Dictionary mapping sequence IDs to reference DNA sequences (strings) [Default: None]\n    - edited_sequences (dict): Nested dictionary: {sequence_id: {read_id: sequence}} containing the edited/mutated sequences for each reference [Default: None]\n  Optional Parameters:\n    - cell_line_info (dict): Dictionary mapping sequence IDs to cell line information (e.g., wildtype, knockout gene) [Default: None]\n    - output_prefix (str): Prefix for output files [Default: cas9_mutation_analysis]\n\nMethod: analyze_crispr_genome_editing\n  Description: Analyzes CRISPR-Cas9 genome editing results by comparing original and edited sequences.\n  Required Parameters:\n    - original_sequence (str): The original DNA sequence before CRISPR-Cas9 editing [Default: None]\n    - edited_sequence (str): The DNA sequence after CRISPR-Cas9 editing [Default: None]\n    - guide_rna (str): The CRISPR guide RNA (crRNA) sequence used for targeting [Default: None]\n  Optional Parameters:\n    - repair_template (str): The homology-directed repair template sequence, if used [Default: None]\n\n\nImport file: biomni.tool.genomics\n=================================\nMethod: annotate_celltype_scRNA\n  Description: Annotate cell types based on gene markers and transferred labels using LLM. After leiden clustering, annotate clusters using differentially expressed genes and optionally incorporate transferred labels from reference datasets.\n  Required Parameters:\n    - adata_filename (str): Name of the AnnData file containing scRNA-seq data [Default: None]\n    - data_dir (str): Directory containing the data files [Default: None]\n    - data_info (str): Information about the scRNA-seq data (e.g., \"homo sapiens, brain tissue, normal\") [Default: None]\n    - data_lake_path (str): Path to the data lake [Default: None]\n  Optional Parameters:\n    - cluster (str): Clustering method to use for cell type annotation [Default: leiden]\n    - llm (str): Language model instance for cell type prediction [Default: claude-3-5-sonnet-20241022]\n    - composition (pd.DataFrame): Transferred cell type composition for each cluster [Default: None]\n\nMethod: get_rna_seq_archs4\n  Description: Given a gene name, fetch RNA-seq expression data showing the top K tissues with highest transcripts-per-million (TPM) values.\n  Required Parameters:\n    - gene_name (str): The gene name for which RNA-seq data is being fetched [Default: None]\n  Optional Parameters:\n    - K (int): The number of tissues to return [Default: 10]\n\nMethod: gene_set_enrichment_analysis\n  Description: Perform enrichment analysis for a list of genes, with optional background gene set and plotting functionality.\n  Required Parameters:\n    - genes (list): List of gene symbols to analyze [Default: None]\n  Optional Parameters:\n    - top_k (int): Number of top pathways to return [Default: 10]\n    - database (str): Database to use for enrichment analysis (e.g., pathway, transcription, ontology) [Default: ontology]\n    - background_list (list): List of background genes to use for enrichment analysis [Default: None]\n    - plot (bool): Generate a bar plot of the top K enrichment results [Default: False]\n\nMethod: perform_chipseq_peak_calling_with_macs2\n  Description: Perform ChIP-seq peak calling using MACS2 to identify genomic regions with significant binding.\n  Required Parameters:\n    - chip_seq_file (str): Path to the ChIP-seq read data file (BAM, BED, or other supported format) [Default: None]\n    - control_file (str): Path to the control/input data file (BAM, BED, or other supported format) [Default: None]\n  Optional Parameters:\n    - output_name (str): Prefix for output files [Default: macs2_output]\n    - genome_size (str): Effective genome size shorthand: 'hs' for human, 'mm' for mouse, etc. [Default: hs]\n    - q_value (float): q-value (minimum FDR) cutoff for peak calling [Default: 0.05]\n\nMethod: analyze_genomic_region_overlap\n  Description: Analyze overlaps between two or more sets of genomic regions.\n  Required Parameters:\n    - region_sets (list): List of genomic region sets. Each item can be either a string path to a BED file or a list of tuples/lists with format (chrom, start, end) or (chrom, start, end, name) [Default: None]\n  Optional Parameters:\n    - output_prefix (str): Prefix for output files [Default: overlap_analysis]\n\n\nImport file: biomni.tool.immunology\n===================================\nMethod: isolate_purify_immune_cells\n  Description: Simulates the isolation and purification of immune cells from tissue samples.\n  Required Parameters:\n    - tissue_type (str): The type of tissue sample (e.g., 'adipose', 'kidney', 'liver', 'lung', 'spleen') [Default: None]\n    - target_cell_type (str): The immune cell population to isolate (e.g., 'macrophages', 'leukocytes', 'T cells') [Default: None]\n  Optional Parameters:\n    - enzyme_type (str): The enzyme used for tissue digestion [Default: collagenase]\n    - macs_antibody (str): Specific antibody for magnetic-assisted cell sorting [Default: None]\n    - digestion_time_min (int): Digestion time in minutes [Default: 45]\n\nMethod: analyze_cfse_cell_proliferation\n  Description: Analyze CFSE-labeled cell samples to quantify cell division and proliferation.\n  Required Parameters:\n    - fcs_file_path (str): Path to the FCS file containing flow cytometry data from CFSE-labeled cells [Default: None]\n  Optional Parameters:\n    - cfse_channel (str): Name of the channel containing CFSE fluorescence data [Default: FL1-A]\n    - lymphocyte_gate (tuple or None): Tuple of (min_fsc, max_fsc, min_ssc, max_ssc) for lymphocyte gating [Default: None]\n\nMethod: analyze_cytokine_production_in_cd4_tcells\n  Description: Analyze cytokine production (IFN-Œ≥, IL-17) in CD4+ T cells after antigen stimulation.\n  Required Parameters:\n    - fcs_files_dict (dict): Dictionary mapping stimulation conditions to FCS file paths. Expected keys: 'unstimulated', 'Mtb300', 'CMV', 'SEB' [Default: None]\n  Optional Parameters:\n    - output_dir (str): Directory to save the results file [Default: ./results]\n\n\nImport file: biomni.tool.synthetic_biology\n==========================================\nMethod: analyze_barcode_sequencing_data\n  Description: Analyze sequencing data to extract, quantify and determine lineage relationships of barcodes.\n  Required Parameters:\n    - input_file (str): Path to the input sequencing file in FASTQ or FASTA format [Default: None]\n  Optional Parameters:\n    - barcode_pattern (str): Regular expression pattern to identify barcodes. If None, will use flanking sequences [Default: None]\n    - flanking_seq_5prime (str): 5' flanking sequence of the barcode region [Default: None]\n    - flanking_seq_3prime (str): 3' flanking sequence of the barcode region [Default: None]\n    - min_count (int): Minimum count threshold for considering a barcode [Default: 5]\n    - output_dir (str): Directory to save output files [Default: ./results]\n\n\nImport file: biomni.tool.systems_biology\n========================================\nMethod: simulate_protein_signaling_network\n  Description: Simulate protein signaling network dynamics using ODE-based logic modeling with normalized Hill functions.\n  Required Parameters:\n    - network_structure (dict): Dictionary defining the network topology. Each key is a target protein and its value is a list of tuples (regulator, regulation_type) where regulation_type is 1 for activation and -1 for inhibition. [Default: None]\n    - reaction_params (dict): Dictionary of reaction parameters. Keys are tuples (regulator, target) and values are dictionaries with keys 'W' (weight), 'n' (Hill coefficient), and 'EC50' (half-maximal effective concentration). [Default: None]\n    - species_params (dict): Dictionary of species parameters. Keys are protein names and values are dictionaries with keys 'tau' (time constant), 'y0' (initial concentration), and 'ymax' (maximum concentration). [Default: None]\n  Optional Parameters:\n    - simulation_time (float): Total simulation time in arbitrary time units. [Default: 100]\n    - time_points (int): Number of time points for the simulation. [Default: 1000]\n\nMethod: query_chatnt\n  Description: Answer functions and properties questions for DNA sequences \n  Required Parameters:\n    - question (str): Questions about the DNA sequence [Default: A]\n    - sequence (str): DNA sequence with potential functions [Default: A]\n  Optional Parameters:\n    - device (int): Device to use for the ChatNT model. Default is -1 (CPU). [Default: -1]\n\n\nImport file: biomni.tool.database\n=================================\nMethod: query_uniprot\n  Description: Query the UniProt REST API using either natural language or a direct endpoint.\n  Required Parameters:\n    - prompt (str): Natural language query about proteins (e.g., \"Find information about human insulin\") [Default: None]\n  Optional Parameters:\n    - endpoint (str): Full or partial UniProt API endpoint URL to query directly (e.g., 'https://rest.uniprot.org/uniprotkb/P01308') [Default: None]\n    - max_results (int): Maximum number of results to return [Default: 5]\n\nMethod: query_alphafold\n  Description: Query the AlphaFold Database API for protein structure predictions or metadata; optionally download structures.\n  Required Parameters:\n    - uniprot_id (str): UniProt accession ID (e.g., 'P12345') [Default: None]\n  Optional Parameters:\n    - endpoint (str): Endpoint: 'prediction', 'summary', or 'annotations' [Default: prediction]\n    - residue_range (str): Residue range as 'start-end' [Default: None]\n    - download (bool): Whether to download structure file [Default: False]\n    - output_dir (str): Directory to save downloaded files [Default: None]\n    - file_format (str): Download format 'pdb' or 'cif' [Default: pdb]\n    - model_version (str): AlphaFold model version (e.g., v4) [Default: v4]\n    - model_number (int): Model number (1-5) [Default: 1]\n\nMethod: query_pdb\n  Description: Query the RCSB PDB database using natural language or a direct structured query.\n  Required Parameters:\n    - prompt (str): Natural language query about protein structures [Default: None]\n  Optional Parameters:\n    - query (dict): Direct RCSB Search API query JSON [Default: None]\n    - max_results (int): Maximum results to return [Default: 3]\n\nMethod: query_kegg\n  Description: Take a natural language prompt and convert it to a structured KEGG API query.\n  Required Parameters:\n    - prompt (str): Natural language query about KEGG data [Default: None]\n  Optional Parameters:\n    - endpoint (str): Direct KEGG endpoint to query [Default: None]\n    - verbose (bool): Return detailed results [Default: True]\n\nMethod: query_stringdb\n  Description: Query the STRING protein interaction database using natural language or direct endpoint.\n  Required Parameters:\n    - prompt (str): Natural language query about protein interactions [Default: None]\n  Optional Parameters:\n    - endpoint (str): Full URL to query directly [Default: None]\n    - download_image (bool): Download image results if endpoint is image [Default: False]\n    - output_dir (str): Directory to save downloaded files [Default: None]\n    - verbose (bool): Return detailed results [Default: True]\n\nMethod: query_cbioportal\n  Description: Query the cBioPortal REST API using natural language or a direct endpoint.\n  Required Parameters:\n    - prompt (str): Natural language query about cancer genomics [Default: None]\n  Optional Parameters:\n    - endpoint (str): API endpoint path or full URL [Default: None]\n    - verbose (bool): Return detailed results [Default: True]\n\nMethod: query_geo\n  Description: Query the NCBI GEO database (GDS/GEOPROFILES) using natural language or direct search term.\n  Required Parameters:\n    - prompt (str): Natural language query about expression data [Default: None]\n  Optional Parameters:\n    - search_term (str): Direct GEO search term [Default: None]\n    - max_results (int): Maximum number of results [Default: 3]\n\nMethod: query_ucsc\n  Description: Query the UCSC Genome Browser API using natural language or a direct endpoint.\n  Required Parameters:\n    - prompt (str): Natural language query about genomic data [Default: None]\n  Optional Parameters:\n    - endpoint (str): Full URL or endpoint spec [Default: None]\n    - verbose (bool): Return detailed results [Default: True]\n\nMethod: query_ensembl\n  Description: Query the Ensembl REST API using natural language or a direct endpoint.\n  Required Parameters:\n    - prompt (str): Natural language query about genomic data [Default: None]\n  Optional Parameters:\n    - endpoint (str): Direct Ensembl endpoint or full URL [Default: None]\n    - verbose (bool): Return detailed results [Default: True]\n\nMethod: query_opentarget\n  Description: Query the OpenTargets Platform API using natural language or a direct GraphQL query.\n  Required Parameters:\n    - prompt (str): Natural language query about targets/diseases [Default: None]\n  Optional Parameters:\n    - query (str): Direct GraphQL query string [Default: None]\n    - variables (dict): Variables for GraphQL [Default: None]\n    - verbose (bool): Return detailed results [Default: False]\n\nMethod: query_reactome\n  Description: Query the Reactome database using natural language or a direct endpoint; optionally download pathway diagrams.\n  Required Parameters:\n    - prompt (str): Natural language query about biological pathways [Default: None]\n  Optional Parameters:\n    - endpoint (str): Direct endpoint or full URL [Default: None]\n    - download (bool): Download pathway diagram if available [Default: False]\n    - output_dir (str): Directory to save downloads [Default: None]\n    - verbose (bool): Return detailed results [Default: True]\n\nMethod: query_remap\n  Description: Query the ReMap database for regulatory elements and transcription factor binding.\n  Required Parameters:\n    - prompt (str): Natural language query about TF binding sites [Default: None]\n  Optional Parameters:\n    - endpoint (str): Full API endpoint to query [Default: None]\n    - verbose (bool): Return detailed results [Default: True]\n\nMethod: query_encode\n  Description: Query the ENCODE Portal API to locate functional genomics data (experiments, files, biosamples, datasets).\n  Required Parameters:\n    - prompt (str): Natural language query about functional genomics data [Default: None]\n  Optional Parameters:\n    - endpoint (str): Direct ENCODE Portal endpoint or full URL [Default: None]\n    - max_results (int|str): Limit for search endpoints (number or 'all') [Default: 25]\n    - verbose (bool): Return detailed results [Default: True]\n\n\nImport file: biomni.tool.protocols\n==================================\nMethod: search_protocols\n  Description: Search protocols.io for public protocols matching a keyword.\n  Required Parameters:\n    - query (str): Most important keyword or phrase to search (title, description, authors) [Default: None]\n\nMethod: get_protocol_details\n  Description: Retrieve detailed metadata for a specific protocols.io protocol by ID.\n  Required Parameters:\n    - protocol_id (int): Numeric protocol ID from protocols.io [Default: None]\n  Optional Parameters:\n    - timeout (int): Request timeout in seconds [Default: 30]\n\nMethod: list_local_protocols\n  Description: List available protocol files in the local biomni/tool/protocols/ directory. Includes protocols from Addgene and Thermo Fisher Scientific.\n  Optional Parameters:\n    - source (str): Filter by source directory (e.g., 'addgene' or 'thermofisher'). If None, lists all protocols. [Default: None]\n\nMethod: read_local_protocol\n  Description: Read the contents of a local protocol file from biomni/tool/protocols/. Use list_local_protocols() first to find available protocol filenames.\n  Required Parameters:\n    - filename (str): Name of the protocol file (e.g., 'Addgene_ Protocol - How to Run an Agarose Gel.txt') [Default: None]\n  Optional Parameters:\n    - source (str): Source directory (e.g., 'addgene' or 'thermofisher'). If None, searches all sources. [Default: None]\n\n\n---\n\nIMPORTANT: When using any function, you MUST first import it from its module. For example:\nfrom [module_name] import [function_name]\n\n- Biological data lake\nYou can access a biological data lake at the following path: /app/data/biomni_data/data_lake.\nBased on your query, I've identified the following most relevant datasets:\nEach item is listed with its description to help you understand its contents.\n----\nMcPAS-TCR.parquet: T-cell receptor sequences and specificity data from McPAS database.\nDepMap_OmicsExpressionProteinCodingGenesTPMLogp1.csv: Gene expression in TPMs for cancer cell lines, including all DepMap models.\ngene_info.parquet: Comprehensive gene information.\nczi_census_datasets_v4.parquet: Datasets from the Chan Zuckerberg Initiative's Cell Census.\ngtex_tissue_gene_tpm.parquet: Gene expression (TPM) across human tissues from GTEx.\nmarker_celltype.parquet: Cell type marker genes for identification.\nproteinatlas.tsv: Protein expression data from Human Protein Atlas.\nDepMap_CRISPRGeneDependency.csv:\n  Gene dependency probability estimates for cancer cell lines, including all\n  DepMap models.\nddinter_alimentary_tract_metabolism.csv:\n  Drug-drug interactions for alimentary tract and metabolism drugs from DDInter\n  2.0 database.\nsgRNA_KO_SP_mouse.txt: sgRNA knockout data for mouse.\nDisGeNET.parquet: Gene-disease associations from multiple sources.\nkg.csv:\n  Precision medicine knowledge graph with 17,080 diseases and 4+ million\n  relationships across biological scales.\nmsigdb_human_c7_immunologic_signature_geneset.parquet: Immunologic signatures from MSigDB.\nmsigdb_human_c2_curated_geneset.parquet: Curated human gene sets from MSigDB.\nmsigdb_human_c3_regulatory_target_geneset.parquet: Regulatory target gene sets from MSigDB.\ngo-plus.json: Gene ontology data for functional gene annotations.\nmsigdb_human_h_hallmark_geneset.parquet: Hallmark gene sets from MSigDB.\n----\n\n- Software Library:\nBased on your query, I've identified the following most relevant libraries that you can use:\nEach library is listed with its description to help you understand its functionality.\n----\nbiopython:\n  [Python Package] A set of tools for biological computation including parsers for\n  bioinformatics files, access to online services, and interfaces to common\n  bioinformatics programs.\nscanpy:\n  [Python Package] A scalable toolkit for analyzing single-cell gene expression\n  data, specifically designed for large datasets using AnnData.\nanndata:\n  [Python Package] A Python package for handling annotated data matrices in memory\n  and on disk, primarily used for single-cell genomics data.\ngget:\n  [Python Package] A toolkit for accessing genomic databases and retrieving\n  sequences, annotations, and other genomic data.\ngseapy:\n  [Python Package] A Python wrapper for Gene Set Enrichment Analysis (GSEA) and\n  visualization.\ncellxgene-census:\n  [Python Package] A tool for accessing and analyzing the CellxGene Census, a\n  collection of single-cell datasets. To download a dataset, use the\n  download_source_h5ad function with the dataset id as the argument\n  (856c1b98-5727-49da-bf0f-151bdb8cb056, no .h5ad extension).\nhyperopt:\n  [Python Package] A Python library for optimizing hyperparameters of machine\n  learning algorithms.\nscvelo:\n  [Python Package] A tool for RNA velocity analysis in single cells using\n  dynamical models.\npysam:\n  [Python Package] A Python module for reading, manipulating and writing genomic\n  data sets in SAM/BAM/VCF/BCF formats.\npyranges:\n  [Python Package] A Python package for interval manipulation with a pandas-like\n  interface.\npybedtools: [Python Package] A Python wrapper for Aaron Quinlan's BEDTools programs.\nrdkit:\n  [Python Package] A collection of cheminformatics and machine learning tools for\n  working with chemical structures and drug discovery.\npandas:\n  [Python Package] A fast, powerful, and flexible data analysis and manipulation\n  library for Python.\nnumpy:\n  [Python Package] The fundamental package for scientific computing with Python,\n  providing support for arrays, matrices, and mathematical functions.\nscipy:\n  [Python Package] A Python library for scientific and technical computing,\n  including modules for optimization, linear algebra, integration, and statistics.\nscikit-learn:\n  [Python Package] A machine learning library featuring various classification,\n  regression, and clustering algorithms.\nmatplotlib:\n  [Python Package] A comprehensive library for creating static, animated, and\n  interactive visualizations in Python.\nseaborn:\n  [Python Package] A statistical data visualization library based on matplotlib\n  with a high-level interface for drawing attractive statistical graphics.\nstatsmodels:\n  [Python Package] A Python module for statistical modeling and econometrics,\n  including descriptive statistics and estimation of statistical models.\nmageck: [Python Package] Analysis of CRISPR screen data.\nigraph: [Python Package] Network analysis and visualization.\nflowkit: [Python Package] Toolkit for processing flow cytometry data.\nhmmlearn: [Python Package] Hidden Markov model analysis.\nloompy:\n  A Python implementation of the Loom file format for efficiently storing and\n  working with large omics datasets.\nFlowIO: A Python package for reading and writing flow cytometry data files.\nFlowUtils: Utilities for processing and analyzing flow cytometry data.\n----\n\n- Note on using R packages and Bash scripts:\n  - R packages: Use subprocess.run(['Rscript', '-e', 'your R code here']) in Python, or use the #!R marker in your execute block.\n  - Bash scripts and commands: Use the #!BASH marker in your execute block for both simple commands and complex shell scripts with variables, loops, conditionals, etc.\n        \n\nIMPORTANT FOR GPT MODELS: You MUST use XML tags <execute> or <solution> in EVERY response. Do not use markdown code blocks (```) - use <execute> tags instead.\n\nUse <think>...</think> tags to show your step-by-step reasoning process before acting.",
            "additional_kwargs": {},
            "response_metadata": {}
        },
        {
            "id": null,
            "name": null,
            "type": "human",
            "content": "Plan and experience a CRISPR screen to identify genes that regulate T cell exhaustion, measured by the change in T cell receptor (TCR) signaling between acute (interleukin-2 [IL-2] only) and chronic (anti-CD3 and IL-2) stimulation conditions. Generate 32 genes that maximize the perturbation effect.",
            "additional_kwargs": {},
            "response_metadata": {}
        },
        {
            "id": null,
            "name": null,
            "type": "ai",
            "content": "<think>\nObservation:\n{\"tools\": [{\"id\": 0, \"name\": \"fetch_supplementary_info_from_doi\", \"description\": \"Fetches supplementary information for a paper given its DOI and saves it to a specified directory.\", \"optional_parameters\": [{\"name\": \"output_dir\", \"type\": \"str\", \"default\": \"supplementary_info\", \"description\": \"Directory to save supplementary files\"}], \"required_parameters\": [{\"name\": \"doi\", \"type\": \"str\", \"default\": null, \"description\": \"The paper DOI\"}]}, {\"id\": 1, \"name\": \"query_arxiv\", \"description\": \"Query arXiv for papers based on the provided search query.\", \"optional_parameters\": [{\"name\": \"max_papers\", \"type\": \"int\", \"default\": 10, \"description\": \"The maximum number of papers to retrieve.\"}], \"required_parameters\": [{\"name\": \"query\", \"type\": \"str\", \"default\": null, \"description\": \"The search query string.\"}]}, {\"id\": 2, \"name\": \"query_scholar\", \"description\": \"Query Google Scholar for papers based on the provided search query and return the first search result.\", \"optional_parameters\": [], \"required_parameters\": [{\"name\": \"query\", \"type\": \"str\", \"default\": null, \"description\": \"The search query string.\"}]}, {\"id\": 3, \"name\": \"query_pubmed\", \"description\": \"Query PubMed for papers based on the provided search query.\", \"optional_parameters\": [{\"name\": \"max_papers\", \"type\": \"int\", \"default\": 10, \"description\": \"The maximum number of papers to retrieve.\"}, {\"name\": \"max_retries\", \"type\": \"int\", \"default\": 3, \"description\": \"Maximum number of retry attempts with modified queries.\"}], \"required_parameters\": [{\"name\": \"query\", \"type\": \"str\", \"default\": null, \"description\": \"The search query string.\"}]}, {\"id\": 4, \"name\": \"search_google\", \"description\": \"Search using Google search and return formatted results.\", \"optional_parameters\": [{\"name\": \"num_results\", \"type\": \"int\", \"default\": 3, \"description\": \"Number of results to return\"}, {\"name\": \"language\", \"type\": \"str\", \"default\": \"en\", \"description\": \"Language code for search results\"}], \"required_parameters\": [{\"name\": \"query\", \"type\": \"str\", \"default\": null, \"description\": \"The search query (e.g., \\\"protocol text or search question\\\")\"}]}, {\"id\": 5, \"name\": \"extract_url_content\", \"description\": \"Extract the text content of a webpage using requests and BeautifulSoup.\", \"optional_parameters\": [], \"required_parameters\": [{\"name\": \"url\", \"type\": \"str\", \"default\": null, \"description\": \"Webpage URL to extract content from\"}]}, {\"id\": 6, \"name\": \"extract_pdf_content\", \"description\": \"Extract text content from a PDF file.\", \"optional_parameters\": [], \"required_parameters\": [{\"name\": \"url\", \"type\": \"str\", \"default\": null, \"description\": \"URL of the PDF file\"}]}, {\"id\": 7, \"name\": \"advanced_web_search_claude\", \"description\": \"Initiate an advanced web search by launching a specialized agent to collect relevant information and citations through multiple rounds of web searches for a given query.\", \"optional_parameters\": [{\"name\": \"max_searches\", \"type\": \"int\", \"default\": 1, \"description\": \"Maximum number of searches\"}, {\"name\": \"max_retries\", \"type\": \"int\", \"default\": 3, \"description\": \"Maximum number of retry attempts with modified queries.\"}], \"required_parameters\": [{\"name\": \"query\", \"type\": \"str\", \"default\": null, \"description\": \"The search query string.\"}]}, {\"id\": 25, \"name\": \"perform_crispr_cas9_genome_editing\", \"description\": \"Simulates CRISPR-Cas9 genome editing process including guide RNA design, delivery, and analysis.\", \"optional_parameters\": [], \"required_parameters\": [{\"name\": \"guide_rna_sequences\", \"type\": \"List[str]\", \"default\": null, \"description\": \"List of guide RNA sequences (20 nucleotides each) targeting the genomic region of interest\"}, {\"name\": \"target_genomic_loci\", \"type\": \"str\", \"default\": null, \"description\": \"Target genomic sequence to be edited (should be longer than guide RNA and contain the target sites)\"}, {\"name\": \"cell_tissue_type\", \"type\": \"str\", \"default\": null, \"description\": \"Type of cell or tissue being edited (affects delivery efficiency and editing outcomes)\"}]}, {\"id\": 45, \"name\": \"perform_facs_cell_sorting\", \"description\": \"Performs Fluorescence-Activated Cell Sorting (FACS) to enrich cell populations based on fluorescence characteristics.\", \"optional_parameters\": [{\"name\": \"threshold_min\", \"type\": \"float\", \"default\": null, \"description\": \"Minimum threshold for the fluorescence parameter. Cells below this value will be excluded\"}, {\"name\": \"threshold_max\", \"type\": \"float\", \"default\": null, \"description\": \"Maximum threshold for the fluorescence parameter. Cells above this value will be excluded\"}, {\"name\": \"output_file\", \"type\": \"str\", \"default\": \"sorted_cells.csv\", \"description\": \"Filename to save the sorted cell population data\"}], \"required_parameters\": [{\"name\": \"cell_suspension_data\", \"type\": \"str\", \"default\": null, \"description\": \"Path to the FCS file containing flow cytometry data\"}, {\"name\": \"fluorescence_parameter\", \"type\": \"str\", \"default\": null, \"description\": \"The fluorescence parameter to use for sorting (e.g., 'GFP', 'FITC', 'PE')\"}]}, {\"id\": 52, \"name\": \"align_sequences\", \"description\": \"Align short sequences (primers) to a longer sequence, allowing for one mismatch. Checks both forward and reverse complement strands.\", \"optional_parameters\": [], \"required_parameters\": [{\"name\": \"long_seq\", \"type\": \"str\", \"default\": null, \"description\": \"Target DNA sequence\"}, {\"name\": \"short_seqs\", \"type\": \"Union[str, List[str]]\", \"default\": null, \"description\": \"Single primer or list of primers\"}]}, {\"id\": 58, \"name\": \"design_knockout_sgrna\", \"description\": \"Design sgRNAs for CRISPR knockout by searching pre-computed sgRNA libraries. Returns optimized guide RNAs for targeting a specific gene.\", \"optional_parameters\": [{\"name\": \"species\", \"type\": \"str\", \"default\": \"human\", \"description\": \"Target organism species\"}, {\"name\": \"num_guides\", \"type\": \"int\", \"default\": 1, \"description\": \"Number of guides to return\"}], \"required_parameters\": [{\"name\": \"gene_name\", \"type\": \"str\", \"default\": null, \"description\": \"Target gene symbol/name (e.g., \\\"EGFR\\\", \\\"TP53\\\")\"}, {\"name\": \"data_lake_path\", \"type\": \"str\", \"default\": null, \"description\": \"Path to the data lake\"}]}, {\"id\": 68, \"name\": \"analyze_cas9_mutation_outcomes\", \"description\": \"Analyzes and categorizes mutations induced by Cas9 at target sites.\", \"optional_parameters\": [{\"name\": \"cell_line_info\", \"type\": \"dict\", \"default\": null, \"description\": \"Dictionary mapping sequence IDs to cell line information (e.g., wildtype, knockout gene)\"}, {\"name\": \"output_prefix\", \"type\": \"str\", \"default\": \"cas9_mutation_analysis\", \"description\": \"Prefix for output files\"}], \"required_parameters\": [{\"name\": \"reference_sequences\", \"type\": \"dict\", \"default\": null, \"description\": \"Dictionary mapping sequence IDs to reference DNA sequences (strings)\"}, {\"name\": \"edited_sequences\", \"type\": \"dict\", \"default\": null, \"description\": \"Nested dictionary: {sequence_id: {read_id: sequence}} containing the edited/mutated sequences for each reference\"}]}, {\"id\": 69, \"name\": \"analyze_crispr_genome_editing\", \"description\": \"Analyzes CRISPR-Cas9 genome editing results by comparing original and edited sequences.\", \"optional_parameters\": [{\"name\": \"repair_template\", \"type\": \"str\", \"default\": null, \"description\": \"The homology-directed repair template sequence, if used\"}], \"required_parameters\": [{\"name\": \"original_sequence\", \"type\": \"str\", \"default\": null, \"description\": \"The original DNA sequence before CRISPR-Cas9 editing\"}, {\"name\": \"edited_sequence\", \"type\": \"str\", \"default\": null, \"description\": \"The DNA sequence after CRISPR-Cas9 editing\"}, {\"name\": \"guide_rna\", \"type\": \"str\", \"default\": null, \"description\": \"The CRISPR guide RNA (crRNA) sequence used for targeting\"}]}, {\"id\": 75, \"name\": \"annotate_celltype_scRNA\", \"description\": \"Annotate cell types based on gene markers and transferred labels using LLM. After leiden clustering, annotate clusters using differentially expressed genes and optionally incorporate transferred labels from reference datasets.\", \"optional_parameters\": [{\"name\": \"cluster\", \"type\": \"str\", \"default\": \"leiden\", \"description\": \"Clustering method to use for cell type annotation\"}, {\"name\": \"llm\", \"type\": \"str\", \"default\": \"claude-3-5-sonnet-20241022\", \"description\": \"Language model instance for cell type prediction\"}, {\"name\": \"composition\", \"type\": \"pd.DataFrame\", \"default\": null, \"description\": \"Transferred cell type composition for each cluster\"}], \"required_parameters\": [{\"name\": \"adata_filename\", \"type\": \"str\", \"default\": null, \"description\": \"Name of the AnnData file containing scRNA-seq data\"}, {\"name\": \"data_dir\", \"type\": \"str\", \"default\": null, \"description\": \"Directory containing the data files\"}, {\"name\": \"data_info\", \"type\": \"str\", \"default\": null, \"description\": \"Information about the scRNA-seq data (e.g., \\\"homo sapiens, brain tissue, normal\\\")\"}, {\"name\": \"data_lake_path\", \"type\": \"str\", \"default\": null, \"description\": \"Path to the data lake\"}]}, {\"id\": 81, \"name\": \"get_rna_seq_archs4\", \"description\": \"Given a gene name, fetch RNA-seq expression data showing the top K tissues with highest transcripts-per-million (TPM) values.\", \"optional_parameters\": [{\"name\": \"K\", \"type\": \"int\", \"default\": 10, \"description\": \"The number of tissues to return\"}], \"required_parameters\": [{\"name\": \"gene_name\", \"type\": \"str\", \"default\": null, \"description\": \"The gene name for which RNA-seq data is being fetched\"}]}, {\"id\": 83, \"name\": \"gene_set_enrichment_analysis\", \"description\": \"Perform enrichment analysis for a list of genes, with optional background gene set and plotting functionality.\", \"optional_parameters\": [{\"name\": \"top_k\", \"type\": \"int\", \"default\": 10, \"description\": \"Number of top pathways to return\"}, {\"name\": \"database\", \"type\": \"str\", \"default\": \"ontology\", \"description\": \"Database to use for enrichment analysis (e.g., pathway, transcription, ontology)\"}, {\"name\": \"background_list\", \"type\": \"list\", \"default\": null, \"description\": \"List of background genes to use for enrichment analysis\"}, {\"name\": \"plot\", \"type\": \"bool\", \"default\": false, \"description\": \"Generate a bar plot of the top K enrichment results\"}], \"required_parameters\": [{\"name\": \"genes\", \"type\": \"list\", \"default\": null, \"description\": \"List of gene symbols to analyze\"}]}, {\"id\": 86, \"name\": \"perform_chipseq_peak_calling_with_macs2\", \"description\": \"Perform ChIP-seq peak calling using MACS2 to identify genomic regions with significant binding.\", \"optional_parameters\": [{\"name\": \"output_name\", \"type\": \"str\", \"default\": \"macs2_output\", \"description\": \"Prefix for output files\"}, {\"name\": \"genome_size\", \"type\": \"str\", \"default\": \"hs\", \"description\": \"Effective genome size shorthand: 'hs' for human, 'mm' for mouse, etc.\"}, {\"name\": \"q_value\", \"type\": \"float\", \"default\": 0.05, \"description\": \"q-value (minimum FDR) cutoff for peak calling\"}], \"required_parameters\": [{\"name\": \"chip_seq_file\", \"type\": \"str\", \"default\": null, \"description\": \"Path to the ChIP-seq read data file (BAM, BED, or other supported format)\"}, {\"name\": \"control_file\", \"type\": \"str\", \"default\": null, \"description\": \"Path to the control/input data file (BAM, BED, or other supported format)\"}]}, {\"id\": 88, \"name\": \"analyze_genomic_region_overlap\", \"description\": \"Analyze overlaps between two or more sets of genomic regions.\", \"optional_parameters\": [{\"name\": \"output_prefix\", \"type\": \"str\", \"default\": \"overlap_analysis\", \"description\": \"Prefix for output files\"}], \"required_parameters\": [{\"name\": \"region_sets\", \"type\": \"list\", \"default\": null, \"description\": \"List of genomic region sets. Each item can be either a string path to a BED file or a list of tuples/lists with format (chrom, start, end) or (chrom, start, end, name)\"}]}, {\"id\": 96, \"name\": \"isolate_purify_immune_cells\", \"description\": \"Simulates the isolation and purification of immune cells from tissue samples.\", \"optional_parameters\": [{\"name\": \"enzyme_type\", \"type\": \"str\", \"default\": \"collagenase\", \"description\": \"The enzyme used for tissue digestion\"}, {\"name\": \"macs_antibody\", \"type\": \"str\", \"default\": null, \"description\": \"Specific antibody for magnetic-assisted cell sorting\"}, {\"name\": \"digestion_time_min\", \"type\": \"int\", \"default\": 45, \"description\": \"Digestion time in minutes\"}], \"required_parameters\": [{\"name\": \"tissue_type\", \"type\": \"str\", \"default\": null, \"description\": \"The type of tissue sample (e.g., 'adipose', 'kidney', 'liver', 'lung', 'spleen')\"}, {\"name\": \"target_cell_type\", \"type\": \"str\", \"default\": null, \"description\": \"The immune cell population to isolate (e.g., 'macrophages', 'leukocytes', 'T cells')\"}]}, {\"id\": 99, \"name\": \"analyze_cfse_cell_proliferation\", \"description\": \"Analyze CFSE-labeled cell samples to quantify cell division and proliferation.\", \"optional_parameters\": [{\"name\": \"cfse_channel\", \"type\": \"str\", \"default\": \"FL1-A\", \"description\": \"Name of the channel containing CFSE fluorescence data\"}, {\"name\": \"lymphocyte_gate\", \"type\": \"tuple or None\", \"default\": null, \"description\": \"Tuple of (min_fsc, max_fsc, min_ssc, max_ssc) for lymphocyte gating\"}], \"required_parameters\": [{\"name\": \"fcs_file_path\", \"type\": \"str\", \"default\": null, \"description\": \"Path to the FCS file containing flow cytometry data from CFSE-labeled cells\"}]}, {\"id\": 100, \"name\": \"analyze_cytokine_production_in_cd4_tcells\", \"description\": \"Analyze cytokine production (IFN-Œ≥, IL-17) in CD4+ T cells after antigen stimulation.\", \"optional_parameters\": [{\"name\": \"output_dir\", \"type\": \"str\", \"default\": \"./results\", \"description\": \"Directory to save the results file\"}], \"required_parameters\": [{\"name\": \"fcs_files_dict\", \"type\": \"dict\", \"default\": null, \"description\": \"Dictionary mapping stimulation conditions to FCS file paths. Expected keys: 'unstimulated', 'Mtb300', 'CMV', 'SEB'\"}]}, {\"id\": 161, \"name\": \"analyze_barcode_sequencing_data\", \"description\": \"Analyze sequencing data to extract, quantify and determine lineage relationships of barcodes.\", \"optional_parameters\": [{\"name\": \"barcode_pattern\", \"type\": \"str\", \"default\": null, \"description\": \"Regular expression pattern to identify barcodes. If None, will use flanking sequences\"}, {\"name\": \"flanking_seq_5prime\", \"type\": \"str\", \"default\": null, \"description\": \"5' flanking sequence of the barcode region\"}, {\"name\": \"flanking_seq_3prime\", \"type\": \"str\", \"default\": null, \"description\": \"3' flanking sequence of the barcode region\"}, {\"name\": \"min_count\", \"type\": \"int\", \"default\": 5, \"description\": \"Minimum count threshold for considering a barcode\"}, {\"name\": \"output_dir\", \"type\": \"str\", \"default\": \"./results\", \"description\": \"Directory to save output files\"}], \"required_parameters\": [{\"name\": \"input_file\", \"type\": \"str\", \"default\": null, \"description\": \"Path to the input sequencing file in FASTQ or FASTA format\"}]}, {\"id\": 170, \"name\": \"simulate_protein_signaling_network\", \"description\": \"Simulate protein signaling network dynamics using ODE-based logic modeling with normalized Hill functions.\", \"optional_parameters\": [{\"name\": \"simulation_time\", \"type\": \"float\", \"default\": 100, \"description\": \"Total simulation time in arbitrary time units.\"}, {\"name\": \"time_points\", \"type\": \"int\", \"default\": 1000, \"description\": \"Number of time points for the simulation.\"}], \"required_parameters\": [{\"name\": \"network_structure\", \"type\": \"dict\", \"default\": null, \"description\": \"Dictionary defining the network topology. Each key is a target protein and its value is a list of tuples (regulator, regulation_type) where regulation_type is 1 for activation and -1 for inhibition.\"}, {\"name\": \"reaction_params\", \"type\": \"dict\", \"default\": null, \"description\": \"Dictionary of reaction parameters. Keys are tuples (regulator, target) and values are dictionaries with keys 'W' (weight), 'n' (Hill coefficient), and 'EC50' (half-maximal effective concentration).\"}, {\"name\": \"species_params\", \"type\": \"dict\", \"default\": null, \"description\": \"Dictionary of species parameters. Keys are protein names and values are dictionaries with keys 'tau' (time constant), 'y0' (initial concentration), and 'ymax' (maximum concentration).\"}]}, {\"id\": 173, \"name\": \"query_chatnt\", \"description\": \"Answer functions and properties questions for DNA sequences \", \"optional_parameters\": [{\"name\": \"device\", \"type\": \"int\", \"default\": -1, \"description\": \"Device to use for the ChatNT model. Default is -1 (CPU).\"}], \"required_parameters\": [{\"name\": \"question\", \"type\": \"str\", \"default\": \"A\", \"description\": \"Questions about the DNA sequence\"}, {\"name\": \"sequence\", \"type\": \"str\", \"default\": \"A\", \"description\": \"DNA sequence with potential functions\"}]}, {\"id\": 177, \"name\": \"query_uniprot\", \"description\": \"Query the UniProt REST API using either natural language or a direct endpoint.\", \"optional_parameters\": [{\"name\": \"endpoint\", \"type\": \"str\", \"default\": null, \"description\": \"Full or partial UniProt API endpoint URL to query directly (e.g., 'https://rest.uniprot.org/uniprotkb/P01308')\"}, {\"name\": \"max_results\", \"type\": \"int\", \"default\": 5, \"description\": \"Maximum number of results to return\"}], \"required_parameters\": [{\"name\": \"prompt\", \"type\": \"str\", \"default\": null, \"description\": \"Natural language query about proteins (e.g., \\\"Find information about human insulin\\\")\"}]}, {\"id\": 178, \"name\": \"query_alphafold\", \"description\": \"Query the AlphaFold Database API for protein structure predictions or metadata; optionally download structures.\", \"optional_parameters\": [{\"name\": \"endpoint\", \"type\": \"str\", \"default\": \"prediction\", \"description\": \"Endpoint: 'prediction', 'summary', or 'annotations'\"}, {\"name\": \"residue_range\", \"type\": \"str\", \"default\": null, \"description\": \"Residue range as 'start-end'\"}, {\"name\": \"download\", \"type\": \"bool\", \"default\": false, \"description\": \"Whether to download structure file\"}, {\"name\": \"output_dir\", \"type\": \"str\", \"default\": null, \"description\": \"Directory to save downloaded files\"}, {\"name\": \"file_format\", \"type\": \"str\", \"default\": \"pdb\", \"description\": \"Download format 'pdb' or 'cif'\"}, {\"name\": \"model_version\", \"type\": \"str\", \"default\": \"v4\", \"description\": \"AlphaFold model version (e.g., v4)\"}, {\"name\": \"model_number\", \"type\": \"int\", \"default\": 1, \"description\": \"Model number (1-5)\"}], \"required_parameters\": [{\"name\": \"uniprot_id\", \"type\": \"str\", \"default\": null, \"description\": \"UniProt accession ID (e.g., 'P12345')\"}]}, {\"id\": 180, \"name\": \"query_pdb\", \"description\": \"Query the RCSB PDB database using natural language or a direct structured query.\", \"optional_parameters\": [{\"name\": \"query\", \"type\": \"dict\", \"default\": null, \"description\": \"Direct RCSB Search API query JSON\"}, {\"name\": \"max_results\", \"type\": \"int\", \"default\": 3, \"description\": \"Maximum results to return\"}], \"required_parameters\": [{\"name\": \"prompt\", \"type\": \"str\", \"default\": null, \"description\": \"Natural language query about protein structures\"}]}, {\"id\": 182, \"name\": \"query_kegg\", \"description\": \"Take a natural language prompt and convert it to a structured KEGG API query.\", \"optional_parameters\": [{\"name\": \"endpoint\", \"type\": \"str\", \"default\": null, \"description\": \"Direct KEGG endpoint to query\"}, {\"name\": \"verbose\", \"type\": \"bool\", \"default\": true, \"description\": \"Return detailed results\"}], \"required_parameters\": [{\"name\": \"prompt\", \"type\": \"str\", \"default\": null, \"description\": \"Natural language query about KEGG data\"}]}, {\"id\": 183, \"name\": \"query_stringdb\", \"description\": \"Query the STRING protein interaction database using natural language or direct endpoint.\", \"optional_parameters\": [{\"name\": \"endpoint\", \"type\": \"str\", \"default\": null, \"description\": \"Full URL to query directly\"}, {\"name\": \"download_image\", \"type\": \"bool\", \"default\": false, \"description\": \"Download image results if endpoint is image\"}, {\"name\": \"output_dir\", \"type\": \"str\", \"default\": null, \"description\": \"Directory to save downloaded files\"}, {\"name\": \"verbose\", \"type\": \"bool\", \"default\": true, \"description\": \"Return detailed results\"}], \"required_parameters\": [{\"name\": \"prompt\", \"type\": \"str\", \"default\": null, \"description\": \"Natural language query about protein interactions\"}]}, {\"id\": 188, \"name\": \"query_cbioportal\", \"description\": \"Query the cBioPortal REST API using natural language or a direct endpoint.\", \"optional_parameters\": [{\"name\": \"endpoint\", \"type\": \"str\", \"default\": null, \"description\": \"API endpoint path or full URL\"}, {\"name\": \"verbose\", \"type\": \"bool\", \"default\": true, \"description\": \"Return detailed results\"}], \"required_parameters\": [{\"name\": \"prompt\", \"type\": \"str\", \"default\": null, \"description\": \"Natural language query about cancer genomics\"}]}, {\"id\": 190, \"name\": \"query_geo\", \"description\": \"Query the NCBI GEO database (GDS/GEOPROFILES) using natural language or direct search term.\", \"optional_parameters\": [{\"name\": \"search_term\", \"type\": \"str\", \"default\": null, \"description\": \"Direct GEO search term\"}, {\"name\": \"max_results\", \"type\": \"int\", \"default\": 3, \"description\": \"Maximum number of results\"}], \"required_parameters\": [{\"name\": \"prompt\", \"type\": \"str\", \"default\": null, \"description\": \"Natural language query about expression data\"}]}, {\"id\": 192, \"name\": \"query_ucsc\", \"description\": \"Query the UCSC Genome Browser API using natural language or a direct endpoint.\", \"optional_parameters\": [{\"name\": \"endpoint\", \"type\": \"str\", \"default\": null, \"description\": \"Full URL or endpoint spec\"}, {\"name\": \"verbose\", \"type\": \"bool\", \"default\": true, \"description\": \"Return detailed results\"}], \"required_parameters\": [{\"name\": \"prompt\", \"type\": \"str\", \"default\": null, \"description\": \"Natural language query about genomic data\"}]}, {\"id\": 193, \"name\": \"query_ensembl\", \"description\": \"Query the Ensembl REST API using natural language or a direct endpoint.\", \"optional_parameters\": [{\"name\": \"endpoint\", \"type\": \"str\", \"default\": null, \"description\": \"Direct Ensembl endpoint or full URL\"}, {\"name\": \"verbose\", \"type\": \"bool\", \"default\": true, \"description\": \"Return detailed results\"}], \"required_parameters\": [{\"name\": \"prompt\", \"type\": \"str\", \"default\": null, \"description\": \"Natural language query about genomic data\"}]}, {\"id\": 194, \"name\": \"query_opentarget\", \"description\": \"Query the OpenTargets Platform API using natural language or a direct GraphQL query.\", \"optional_parameters\": [{\"name\": \"query\", \"type\": \"str\", \"default\": null, \"description\": \"Direct GraphQL query string\"}, {\"name\": \"variables\", \"type\": \"dict\", \"default\": null, \"description\": \"Variables for GraphQL\"}, {\"name\": \"verbose\", \"type\": \"bool\", \"default\": false, \"description\": \"Return detailed results\"}], \"required_parameters\": [{\"name\": \"prompt\", \"type\": \"str\", \"default\": null, \"description\": \"Natural language query about targets/diseases\"}]}, {\"id\": 200, \"name\": \"query_reactome\", \"description\": \"Query the Reactome database using natural language or a direct endpoint; optionally download pathway diagrams.\", \"optional_parameters\": [{\"name\": \"endpoint\", \"type\": \"str\", \"default\": null, \"description\": \"Direct endpoint or full URL\"}, {\"name\": \"download\", \"type\": \"bool\", \"default\": false, \"description\": \"Download pathway diagram if available\"}, {\"name\": \"output_dir\", \"type\": \"str\", \"default\": null, \"description\": \"Directory to save downloads\"}, {\"name\": \"verbose\", \"type\": \"bool\", \"default\": true, \"description\": \"Return detailed results\"}], \"required_parameters\": [{\"name\": \"prompt\", \"type\": \"str\", \"default\": null, \"description\": \"Natural language query about biological pathways\"}]}, {\"id\": 204, \"name\": \"query_remap\", \"description\": \"Query the ReMap database for regulatory elements and transcription factor binding.\", \"optional_parameters\": [{\"name\": \"endpoint\", \"type\": \"str\", \"default\": null, \"description\": \"Full API endpoint to query\"}, {\"name\": \"verbose\", \"type\": \"bool\", \"default\": true, \"description\": \"Return detailed results\"}], \"required_parameters\": [{\"name\": \"prompt\", \"type\": \"str\", \"default\": null, \"description\": \"Natural language query about TF binding sites\"}]}, {\"id\": 214, \"name\": \"query_encode\", \"description\": \"Query the ENCODE Portal API to locate functional genomics data (experiments, files, biosamples, datasets).\", \"optional_parameters\": [{\"name\": \"endpoint\", \"type\": \"str\", \"default\": null, \"description\": \"Direct ENCODE Portal endpoint or full URL\"}, {\"name\": \"max_results\", \"type\": \"int|str\", \"default\": 25, \"description\": \"Limit for search endpoints (number or 'all')\"}, {\"name\": \"verbose\", \"type\": \"bool\", \"default\": true, \"description\": \"Return detailed results\"}], \"required_parameters\": [{\"name\": \"prompt\", \"type\": \"str\", \"default\": null, \"description\": \"Natural language query about functional genomics data\"}]}, {\"id\": 220, \"name\": \"search_protocols\", \"description\": \"Search protocols.io for public protocols matching a keyword.\", \"optional_parameters\": [], \"required_parameters\": [{\"name\": \"query\", \"type\": \"str\", \"default\": null, \"description\": \"Most important keyword or phrase to search (title, description, authors)\"}]}, {\"id\": 221, \"name\": \"get_protocol_details\", \"description\": \"Retrieve detailed metadata for a specific protocols.io protocol by ID.\", \"optional_parameters\": [{\"name\": \"timeout\", \"type\": \"int\", \"default\": 30, \"description\": \"Request timeout in seconds\"}], \"required_parameters\": [{\"name\": \"protocol_id\", \"type\": \"int\", \"default\": null, \"description\": \"Numeric protocol ID from protocols.io\"}]}, {\"id\": 222, \"name\": \"list_local_protocols\", \"description\": \"List available protocol files in the local biomni/tool/protocols/ directory. Includes protocols from Addgene and Thermo Fisher Scientific.\", \"optional_parameters\": [{\"name\": \"source\", \"type\": \"str\", \"default\": null, \"description\": \"Filter by source directory (e.g., 'addgene' or 'thermofisher'). If None, lists all protocols.\"}], \"required_parameters\": []}, {\"id\": 223, \"name\": \"read_local_protocol\", \"description\": \"Read the contents of a local protocol file from biomni/tool/protocols/. Use list_local_protocols() first to find available protocol filenames.\", \"optional_parameters\": [{\"name\": \"source\", \"type\": \"str\", \"default\": null, \"description\": \"Source directory (e.g., 'addgene' or 'thermofisher'). If None, searches all sources.\"}], \"required_parameters\": [{\"name\": \"filename\", \"type\": \"str\", \"default\": null, \"description\": \"Name of the protocol file (e.g., 'Addgene_ Protocol - How to Run an Agarose Gel.txt')\"}]}], \"know_how\": [{\"id\": \"sgRNA_design_guide\", \"name\": \"sgRNA Design Guide: Three-Tiered Approach\", \"content\": \"# sgRNA Design Guide: Three-Tiered Approach\\n\\n## Citations and Acknowledgments\\n\\n### If you use validated sgRNAs from our database (Option 1):\\n- **Database Source**: Addgene (https://www.addgene.org)\\n- **Citation**: Always cite the original publication associated with each sgRNA using the PubMed ID provided in the database\\n- **Acknowledgment**: \\\"Validated sgRNA sequences obtained from Addgene (https://www.addgene.org/crispr/reference/grna-sequence/)\\\"\\n\\n### If you use CRISPick designs (Option 2):\\n- **Acknowledgment Statement**: \\\"Guide designs provided by the CRISPick web tool of the GPP at the Broad Institute\\\"\\n- **Citation for Cas9 designs (SpCas9, SaCas9)**: Sanson KR, et al. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nat Commun. 2018;9(1):5416. PMID: 30575746\\n- **Citation for Cas12a designs (AsCas12a, enAsCas12a)**: DeWeirdt PC, et al. Optimization of AsCas12a for combinatorial genetic screens in human cells. Nat Biotechnol. 2021;39(1):94-104. PMID: 32661438\\n  - Note: This paper describes enAsCas12a optimization; specify which variant you used in your methods\\n\\n## Overview\\n\\nThis guide provides a three-tiered approach to sgRNA design, prioritizing validated sequences before moving to computational predictions. Always start with Option 1 and proceed to subsequent options only if needed.\\n\\n\\n## Option 1: Search Validated sgRNA Sequences (Recommended First)\\n\\n### 1.1 Search for Validated sgRNAs\\n\\n**IMPORTANT**: You MUST complete BOTH Method 1 AND Method 2 before proceeding to Option 2. Do not skip Method 2 even if Method 1 finds no results.\\n\\n#### Method 1: Search Our Database (Fastest)\\n\\nWe maintain a curated database of 300+ validated sgRNA sequences from Addgene with experimental evidence.\\n\\n**Location**: `biomni/know_how/resource/addgene_grna_sequences.csv`\\n\\n**Search the database**:\\n```python\\nimport pandas as pd\\n\\n# Load the database\\ndf = pd.read_csv('addgene_grna_sequences.csv')\\n\\n# Search for your gene\\ngene_name = \\\"TP53\\\"\\nresults = df[df['Target_Gene'].str.upper() == gene_name.upper()]\\n\\n# Filter by species and application\\nresults_filtered = results[\\n    (results['Target_Species'] == 'H. sapiens') &\\n    (results['Application'] == 'cut')  # or 'activate', 'RNA targeting'\\n]\\n\\n# Display results with references\\nprint(results_filtered[['Target_Gene', 'Target_Sequence',\\n                        'Plasmid_ID', 'PubMed_ID', 'Depositor']])\\n```\\n\\n**Database columns**:\\n- `Target_Gene`: Gene symbol\\n- `Target_Species`: Organism (H. sapiens, M. musculus, etc.)\\n- `Target_Sequence`: 20bp sgRNA sequence (5' to 3')\\n- `Application`: cut (knockout), activate (CRISPRa), RNA targeting (CRISPRi)\\n- `Cas9_Species`: S. pyogenes, S. aureus, etc.\\n- `Plasmid_ID`: Addgene plasmid number\\n- `Plasmid_URL`: Direct link to plasmid page\\n- `PubMed_ID`: **Publication reference** (cite this in your work)\\n- `PubMed_URL`: Direct link to paper\\n- `Depositor`: Research lab that contributed the sequence\\n\\n#### Method 2: Advanced Web Search (REQUIRED - Do Not Skip)\\n\\n**CRITICAL**: Even if Method 1 found no results, you MUST perform this literature search before moving to Option 2. Many validated sgRNAs are published in literature but not in the Addgene database.\\n\\nUse `advanced_web_search_claude` from `biomni.tool.literature` to find validated sgRNAs from literature and databases:\\n\\n```python\\nfrom biomni.tool.literature import advanced_web_search_claude\\n\\n# Example usage\\nresults = advanced_web_search_claude(\\\"sgRNA TP53 validated H. sapiens experimental\\\")\\n```\\n\\n**Search queries to try (use multiple):**\\n```\\n\\\"sgRNA\\\" OR \\\"guide RNA\\\" \\\"[GENE_NAME]\\\" validated experimental\\n\\\"CRISPR knockout\\\" \\\"[GENE_NAME]\\\" sgRNA sequence validated\\n\\\"[GENE_NAME]\\\" sgRNA \\\"cutting efficiency\\\" OR \\\"on-target\\\"\\n\\\"[GENE_NAME]\\\" \\\"guide sequence\\\" CRISPR validated\\n```\\n\\n**Example for TP53:**\\n```\\n\\\"sgRNA\\\" \\\"TP53\\\" validated \\\"H. sapiens\\\" experimental\\n\\\"CRISPR knockout\\\" \\\"TP53\\\" guide sequence validated\\n```\\n\\n**What to search for in results:**\\n- Published papers with validated sgRNA sequences\\n- Supplementary materials containing sgRNA sequences\\n- Other CRISPR databases (e.g., GenScript, Horizon Discovery)\\n- Laboratory protocols with specific sgRNA sequences\\n\\n**IMPORTANT**: Spend adequate time searching literature. Look through at least the first 10-15 search results and check supplementary materials of relevant papers.\\n\\n#### What to Do with Results:\\n\\n‚úÖ **If you find matching sgRNAs (from either method):**\\n1. **Record the sgRNA sequence** (20bp target sequence)\\n2. **Note the reference**:\\n   - From database: Use `PubMed_ID` to cite the original paper\\n   - From web search: Record the publication DOI/PubMed ID\\n3. **Record validation details**: Cell line, cutting efficiency, any reported off-targets\\n\\n\\n**Example result format:**\\n```\\nGene: TP53\\nsgRNA sequence: GAGGTTGTGAGGCGCTGCCC\\nSpecies: H. sapiens (human)\\nApplication: Knockout (cut)\\nReference: PubMed ID 24336569 (Ran et al., 2013)\\nValidation: Tested in HEK293T cells, 85% cutting efficiency\\n```\\n\\n‚ùå **If no matches found in BOTH Method 1 AND Method 2:**\\nOnly then proceed to **Option 2: Download CRISPick Dataset**\\n\\n\\n## Option 2: Download Pre-Computed sgRNAs from CRISPick\\n\\n### When to Use This Option?\\n- No validated sgRNAs found in Addgene\\n- Need comprehensive coverage of a gene\\n- Want multiple sgRNA options with predicted scores\\n- Working with genome-scale screening\\n\\n### 2.1 Overview of CRISPick\\n\\n**CRISPick** (from Broad Institute GPP) provides pre-computed sgRNA designs for entire genomes with 238 available datasets covering:\\n- Human (GRCh38, GRCh37)\\n- Mouse (GRCm38, GRCm39)\\n- Dog, Cow, Monkey, and other model organisms\\n- Multiple Cas enzymes (SpCas9, SaCas9, AsCas12a, enAsCas12a)\\n  - **IMPORTANT**: AsCas12a and enAsCas12a are DIFFERENT enzymes\\n  - **AsCas12a**: Wild-type Acidaminococcus sp. Cas12a\\n  - **enAsCas12a**: Enhanced variant with improved activity\\n  - **Critical**: sgRNAs designed for enAsCas12a may NOT work with wild-type AsCas12a\\n  - Always match the dataset to your specific Cas12a variant\\n- Different applications (knockout, activation, inhibition)\\n\\n### 2.2 Find the Download Link\\n\\n**All 238 download links are available in**: `biomni/know_how/resource/CRISPick_download_links.txt`\\n\\n#### Step 1: Understand File Naming Convention\\n\\nFiles are named: `sgRNA_design_{TAXID}_{GENOME}_{CAS}_{APPLICATION}_{ALGORITHM}_{SOURCE}_{DATE}.txt.gz`\\n\\n**Common datasets:**\\n\\n| Organism | Genome | Cas9 | Application | Search Pattern |\\n|-|--||-|-|\\n| Human | GRCh38 | SpCas9 | Knockout | `9606_GRCh38_SpyoCas9_CRISPRko` |\\n| Human | GRCh38 | SpCas9 | Activation | `9606_GRCh38_SpyoCas9_CRISPRa` |\\n| Human | GRCh38 | SaCas9 | Knockout | `9606_GRCh38_SaurCas9_CRISPRko` |\\n| Mouse | GRCm38 | SpCas9 | Knockout | `10090_GRCm38_SpyoCas9_CRISPRko` |\\n| Mouse | GRCm38 | SpCas9 | Activation | `10090_GRCm38_SpyoCas9_CRISPRa` |\\n\\n**Key components:**\\n- **TAXID**: `9606` (Human), `10090` (Mouse), `9615` (Dog), `9913` (Cow)\\n- **CAS**:\\n  - `SpyoCas9` (SpCas9, NGG PAM)\\n  - `SaurCas9` (SaCas9, NNGRRT PAM)\\n  - `AsCas12a` (Wild-type Cas12a, TTTV PAM)\\n  - `enAsCas12a` (Enhanced Cas12a, TTTV PAM)\\n  - **WARNING**: Do NOT use AsCas12a datasets if you have enAsCas12a, and vice versa\\n- **APPLICATION**: `CRISPRko` (knockout), `CRISPRa` (activation), `CRISPRi` (inhibition)\\n\\n#### Step 2: Find Your Download URL\\n\\n```bash\\n# Search the download links file\\ngrep \\\"9606_GRCh38_SpyoCas9_CRISPRko\\\" biomni/know_how/resource/CRISPick_download_links.txt\\n\\n# Or for mouse\\ngrep \\\"10090_GRCm38_SpyoCas9_CRISPRko\\\" biomni/know_how/resource/CRISPick_download_links.txt\\n```\\n\\n#### Step 3: Download and Extract\\n\\n```bash\\n# Copy the URL from download_links.txt, then:\\nwget [PASTE_URL_HERE]\\n\\n# Extract the file\\ngunzip sgRNA_design_*.txt.gz\\n```\\n\\n**File sizes**: Knockout (300-700 MB), Activation (50-100 MB), Summary files (1-3 MB)\\n\\n### 2.4 Understanding the File Format\\n\\nThe `.txt` file is tab-delimited. Column names differ between knockout and activation/inhibition datasets.\\n\\n**Essential Columns (All files):**\\n- **sgRNA Sequence**: The 20bp guide RNA sequence (5' to 3')\\n- **Target Gene Symbol**: Gene name (e.g., \\\"TP53\\\", \\\"BRCA1\\\")\\n- **Combined Rank**: Overall ranking (lower = better) - **Use this by default**\\n- **On-Target Rank**: Ranking by efficiency only (lower = better)\\n- **Off-Target Rank**: Ranking by specificity only (lower = better)\\n- **PAM Sequence**: The PAM sequence (e.g., \\\"AGG\\\", \\\"TGG\\\")\\n\\n**Knockout-specific columns:**\\n- **sgRNA Cut Position (1-based)**: Genomic coordinate of cut site\\n- **Exon Number**: Which exon is targeted\\n- **Target Cut %**: Percentage of protein affected\\n\\n**Activation/Inhibition-specific columns:**\\n- **sgRNA 'Cut' Position**: Position relative to gene\\n- **sgRNA 'Cut' Site TSS Offset**: Distance from transcription start site (bp)\\n- **DHS Score**: DNase hypersensitivity score (for CRISPRa)\\n\\n### 2.5 Extract and Select sgRNAs\\n\\n#### Step 1: Load Data and Filter for Your Gene\\n\\n```python\\nimport pandas as pd\\n\\n# Load the dataset\\ndf = pd.read_csv('sgRNA_design_9606_GRCh38_SpyoCas9_CRISPRko_*.txt',\\n                 sep='\\\\t', low_memory=False)\\n\\n# Filter for your gene\\ngene_name = \\\"TP53\\\"\\ngene_sgrnas = df[df['Target Gene Symbol'] == gene_name].copy()\\n\\nprint(f\\\"Found {len(gene_sgrnas)} sgRNAs for {gene_name}\\\")\\n```\\n\\n#### Step 2: Select Top sgRNAs\\n\\n**Default: Use Combined Rank (balances efficiency and specificity)**\\n```python\\n# Sort by Combined Rank (lower is better)\\ntop_sgrnas = gene_sgrnas.nsmallest(10, 'Combined Rank')\\n\\nprint(top_sgrnas[['sgRNA Sequence', 'Combined Rank',\\n                   'Exon Number', 'sgRNA Cut Position (1-based)']])\\n```\\n\\n**Option A: Prioritize On-Target Efficiency**\\n```python\\n# Sort by On-Target Rank (for maximum cutting efficiency)\\nefficient_sgrnas = gene_sgrnas.nsmallest(10, 'On-Target Rank')\\n```\\n\\n**Option B: Prioritize Off-Target Specificity**\\n```python\\n# Sort by Off-Target Rank (for maximum specificity)\\nspecific_sgrnas = gene_sgrnas.nsmallest(10, 'Off-Target Rank')\\n```\\n\\n#### Step 3: Filter by Custom Criteria (Optional)\\n\\n**Filter by Exon Number:**\\n```python\\n# Target specific exon (e.g., exon 5)\\nexon5_sgrnas = gene_sgrnas[gene_sgrnas['Exon Number'] == 5]\\ntop_exon5 = exon5_sgrnas.nsmallest(5, 'Combined Rank')\\n```\\n\\n**Filter by Genomic Position:**\\n```python\\n# Target specific genomic range\\nposition_filtered = gene_sgrnas[\\n    (gene_sgrnas['sgRNA Cut Position (1-based)'] >= 7572000) &\\n    (gene_sgrnas['sgRNA Cut Position (1-based)'] <= 7575000)\\n]\\n```\\n\\n**Target Early Exons for Knockout:**\\n```python\\n# Get sgRNAs from first 3 exons\\nearly_exons = gene_sgrnas[gene_sgrnas['Exon Number'] <= 3]\\ntop_early = early_exons.nsmallest(10, 'Combined Rank')\\n```\\n\\n**Filter by Target Cut Percentage:**\\n```python\\n# Target sgRNAs that affect significant portion of protein\\nhigh_impact = gene_sgrnas[gene_sgrnas['Target Cut %'] <= 50]  # Cut in first 50%\\ntop_high_impact = high_impact.nsmallest(10, 'Combined Rank')\\n```\\n\\n#### Step 4: Select Multiple sgRNAs for Validation\\n\\n```python\\n# Get top 4 sgRNAs from different exons for redundancy\\nfinal_selection = gene_sgrnas.sort_values('Combined Rank').groupby('Exon Number').head(1).head(4)\\n\\n# Save results\\nfinal_selection.to_csv(f'{gene_name}_selected_sgRNAs.csv', index=False)\\n\\nprint(\\\"\\\\nSelected sgRNAs:\\\")\\nprint(final_selection[['sgRNA Sequence', 'Exon Number', 'Combined Rank']])\\n```\\n\\n### 2.6 What to Do with Results\\n\\n‚úÖ **Once you have selected sgRNAs:**\\n1. Choose **3-4 sgRNAs** (use Combined_Rank by default)\\n\\n‚ùå **If dataset doesn't cover your gene or organism:**\\nProceed to **Option 3: De Novo sgRNA Design**\\n\\n\\n## Option 3: General sgRNA Design Guidelines (Last Resort)\\n\\n### When to Use This Option?\\n- Gene not covered in CRISPick datasets\\n- Non-model organism\\n- Custom design requirements\\n\\n### General Design Rules\\n\\n#### Essential Requirements:\\n1. **Length**:\\n   - 20 bp for SpCas9 and SaCas9\\n   - 23-25 bp for Cas12a variants (AsCas12a, enAsCas12a)\\n2. **PAM sequence**:\\n   - **SpCas9**: Requires **NGG** immediately after target (3' end)\\n   - **SaCas9**: Requires **NNGRRT** immediately after target (3' end)\\n   - **AsCas12a** (wild-type): Requires **TTTV** before target (5' end)\\n   - **enAsCas12a** (enhanced): Requires **TTTV** before target (5' end)\\n   - **CRITICAL**: Guides designed for enAsCas12a may not work with wild-type AsCas12a due to different activity profiles\\n3. **GC content**: 40-60% is optimal\\n4. **Avoid**:\\n   - TTTT sequences (terminates transcription)\\n   - Long runs of same nucleotide (>4 repeats)\\n\\n#### Target Location:\\n- **For knockout**: Target early exons (first 50% of gene)\\n- **For activation**: Target -200 to +1 bp from transcription start site (TSS)\\n- **For inhibition**: Target -50 to +300 bp from TSS\\n\\n#### Best Practices:\\n- **Test 3-4 different sgRNAs** per target gene\\n- Select sgRNAs with high efficiency scores (>0.5) and minimal off-targets\\n- Validate experimentally with Sanger sequencing\\n\\n\\n## Quick Start Examples\\n\\n### Example 1: Knockout TP53 in Human Cells\\n\\n**Step 1**: Check Addgene\\n```python\\ndf = pd.read_csv('addgene_grna_sequences.csv')\\ntp53_results = df[(df['Target_Gene'] == 'TP53') &\\n                  (df['Target_Species'] == 'H. sapiens') &\\n                  (df['Application'] == 'cut')]\\n# Result: Found 0 entries ‚Üí Proceed to Option 2\\n```\\n\\n**Step 2**: Download CRISPick dataset\\n```bash\\n# Download human GRCh38 SpCas9 knockout dataset\\nwget https://portals.broadinstitute.org/gppx/public/sgrna_design/api/downloads/\\\\\\nsgRNA_design_9606_GRCh38_SpyoCas9_CRISPRko_RS3seq-Chen2013+RS3target_NCBI_20241104.txt.gz\\n\\ngunzip sgRNA_design_9606_GRCh38_SpyoCas9_CRISPRko_*.txt.gz\\n```\\n\\n**Step 3**: Extract TP53 sgRNAs\\n```python\\ndf = pd.read_csv('sgRNA_design_9606_GRCh38_SpyoCas9_CRISPRko_*.txt', sep='\\\\t')\\ntp53 = df[df['Gene_Symbol'] == 'TP53']\\ntop_sgrnas = tp53[\\n    (tp53['sgRNA_score'] > 0.6) &\\n    (tp53['Off_target_stringency'] > 0.5)\\n].sort_values('sgRNA_score', ascending=False).head(4)\\n\\nprint(top_sgrnas[['sgRNA_sequence', 'sgRNA_score', 'Exon_ID']])\\n```\\n\\n### Example 2: Activate OCT4 in Human iPSCs\\n\\n**Step 1**: Check Addgene\\n```python\\noct4_results = df[(df['Target_Gene'] == 'OCT4') &\\n                  (df['Application'] == 'activate')]\\n# Found 1 validated sgRNA!\\nprint(oct4_results['Target_Sequence'].values[0])\\n# Use this sequence ‚úÖ\\n```\\n\\n\\n**Remember**: Always start with validated sequences (Option 1), then move to pre-computed designs (Option 2), and only use de novo design (Option 3) when necessary. Testing 3-4 sgRNAs per gene is standard practice regardless of prediction scores.\", \"metadata\": {\"authors\": \"Biomni Team\", \"license\": \"CC BY 4.0\", \"version\": \"1.0\", \"last_updated\": \"November 2025\", \"commercial_use\": \"‚úÖ Allowed\", \"short_description\": \"Comprehensive guide for finding or designing sgRNAs using validated sequences, CRISPick datasets, or de novo design tools.\"}, \"description\": \"Comprehensive guide for finding or designing sgRNAs using validated sequences, CRISPick datasets, or de novo design tools.\"}], \"data_lake\": [\"McPAS-TCR.parquet\", \"DepMap_OmicsExpressionProteinCodingGenesTPMLogp1.csv\", \"gene_info.parquet\", \"czi_census_datasets_v4.parquet\", \"gtex_tissue_gene_tpm.parquet\", \"marker_celltype.parquet\", \"proteinatlas.tsv\", \"DepMap_CRISPRGeneDependency.csv\", \"ddinter_alimentary_tract_metabolism.csv\", \"sgRNA_KO_SP_mouse.txt\", \"DisGeNET.parquet\", \"kg.csv\", \"msigdb_human_c7_immunologic_signature_geneset.parquet\", \"msigdb_human_c2_curated_geneset.parquet\", \"msigdb_human_c3_regulatory_target_geneset.parquet\", \"go-plus.json\", \"msigdb_human_h_hallmark_geneset.parquet\"], \"libraries\": [\"biopython\", \"scanpy\", \"anndata\", \"gget\", \"gseapy\", \"cellxgene-census\", \"hyperopt\", \"scvelo\", \"pysam\", \"pyranges\", \"pybedtools\", \"rdkit\", \"pandas\", \"numpy\", \"scipy\", \"scikit-learn\", \"matplotlib\", \"seaborn\", \"statsmodels\", \"mageck\", \"igraph\", \"flowkit\", \"hmmlearn\", \"loompy\", \"FlowIO\", \"FlowUtils\"]}\n\n[{'text': 'TOOLS: [0, 1, 2, 3, 4, 5, 6, 7, 25, 45, 52, 58, 68, 69, 75, 81, 83, 86, 88, 96, 99, 100, 161, 170, 173, 177, 178, 180, 182, 183, 188, 190, 192, 193, 194, 200, 204, 214, 220, 221, 222, 223]\\n\\nDATA_LAKE: [13, 19, 21, 24, 26, 27, 32, 34, 35, 41, 49, 52, 59, 63, 64, 67, 72]\\n\\nLIBRARIES: [0, 2, 4, 10, 12, 14, 15, 16, 17, 19, 20, 21, 28, 29, 30, 31, 32, 33, 34, 52, 53, 64, 65, 71, 75, 76]\\n\\nKNOW_HOW: [0]', 'type': 'text', 'annotations': []}]\n\nObservation:\n{\"messages\": [{\"id\": null, \"name\": null, \"type\": \"human\", \"content\": \"Plan and experience a CRISPR screen to identify genes that regulate T cell exhaustion, measured by the change in T cell receptor (TCR) signaling between acute (interleukin-2 [IL-2] only) and chronic (anti-CD3 and IL-2) stimulation conditions. Generate 32 genes that maximize the perturbation effect.\", \"additional_kwargs\": {}, \"response_metadata\": {}}, {\"id\": null, \"name\": null, \"type\": \"ai\", \"content\": \"<solution>\\n1. [‚úì] Clarify the biological goal and constraints based on user prompt  \\n2. [‚úì] Define a conceptual CRISPR screen design (cell model, library, readout, conditions)  \\n3. [‚úì] Identify pathways and gene classes most likely to regulate T cell exhaustion and TCR signaling  \\n4. [‚úì] Propose a realistic CRISPR screening strategy (pooled vs arrayed; KO vs CRISPRi/a; controls)  \\n5. [‚úì] Narrow down to a focused list of 32 high-priority genes predicted to maximally perturb TCR signaling differences between acute vs chronic stimulation  \\n6. [‚úì] For each gene, briefly justify inclusion and expected direction of effect  \\n7. [‚úì] Summarize how these 32-gene set would be used in a ‚Äúmini-screen‚Äù and how to interpret outcomes  \\n\\n---\\n\\nBelow I both (a) outline how you would design and interpret the screen, and (b) give a concrete, curated list of 32 genes with rationale.\\n\\n---\\n\\n## 1. Biological objective restated\\n\\nYou want to:\\n\\n- Perform a CRISPR screen in T cells  \\n- Compare **TCR signaling output** under:\\n  - **Acute condition:** IL‚Äë2 only (minimal TCR engagement; survival/proliferation cue)\\n  - **Chronic condition:** anti‚ÄëCD3 + IL‚Äë2 (persistent TCR signaling ‚Üí exhaustion-like state)\\n- Readout: A measure of **TCR signaling strength and/or exhaustion state** that changes between these two conditions (e.g., NFAT or NF‚ÄëŒ∫B reporter, CD69/PD‚Äë1/TOX expression, phospho‚ÄëZAP70/ERK, or functional cytokine output)\\n- Design a focused library of **32 genes** whose perturbation (KO or CRISPRi/a) is expected to maximize the difference in TCR signaling between acute and chronic conditions (i.e., strongly modulate exhaustion).\\n\\nKey idea: choose genes that are:\\n- Core exhaustion TFs and epigenetic regulators  \\n- Coinhibitory receptors & proximal signaling nodes  \\n- Cytokine pathway modulators that interact with IL‚Äë2 and chronic TCR signaling  \\n- A few positive regulators to ‚Äúbreak‚Äù exhaustion and a few brakes to enforce it  \\n\\n---\\n\\n## 2. Conceptual CRISPR screen design\\n\\n### Cell model\\n- **Primary human CD8+ T cells** from healthy donors, or an exhaustion-prone T‚Äëcell line (e.g., Jurkat with appropriate reporter) if feasibility is an issue.\\n- Engineering:\\n  - Lentiviral Cas9 or CRISPRi (dCas9-KRAB) line\\n  - Introduce TCR signaling reporter (e.g., NFAT‚ÄëGFP, NF‚ÄëŒ∫B‚ÄëGFP, or IL‚Äë2 promoter‚ÄìGFP).\\n\\n### Stimulation conditions\\n\\n1. **Acute-like condition (‚ÄúIL‚Äë2 only‚Äù)**\\n   - Cells cultured in IL‚Äë2 (e.g., 50‚Äì100 IU/mL) without continuous TCR engagement.\\n   - ‚ÄúBaseline‚Äù TCR signaling low; IL‚Äë2R‚ÄìSTAT5 pathway active.\\n\\n2. **Chronic-like condition (‚Äúanti‚ÄëCD3 + IL‚Äë2‚Äù)**\\n   - Plate-bound or bead-conjugated anti‚ÄëCD3 plus IL‚Äë2 for several days to weeks.\\n   - Sustained TCR signal drives:\\n     - PD‚Äë1, LAG‚Äë3, TIM‚Äë3, CTLA‚Äë4, TIGIT upregulation\\n     - Transcriptional and epigenetic program: TOX, NR4A family, NFAT with low AP‚Äë1, BATF/IRF4 changes\\n     - Decreased effector cytokines (IFN‚ÄëŒ≥, TNF) over time.\\n\\n### Readout options (to connect to CRISPR perturbations)\\n\\nExamples for a pooled screen:\\n- **FACS‚Äëbased pooled screen**:\\n  - Reporter: NFAT‚ÄëGFP or NF‚ÄëŒ∫B‚ÄëGFP.\\n  - Sort high vs low GFP under each condition; sequence sgRNAs.\\n  - Differential enrichment reflects genes that change the chronic vs acute ratio of reporter activity.\\n\\n- **Surface exhaustion markers**:\\n  - Label PD‚Äë1, TIM‚Äë3, CD39, etc; sort high vs low PD‚Äë1 and sequence sgRNAs.\\n\\nFor a **32‚Äëgene mini-screen**, an arrayed format is feasible:\\n- Transduce or electroporate 1‚Äì3 gRNAs per gene in 96‚Äëwell plates.\\n- Measure:\\n  - NFAT‚ÄëGFP MFI\\n  - pZAP70 / pERK by phospho‚Äëflow\\n  - PD‚Äë1, TOX, TIM‚Äë3 expression\\n  - Cytokine production (IFN‚ÄëŒ≥, TNF, IL‚Äë2) by ELISA/ICS\\n  - Compare readout between IL‚Äë2 only and anti‚ÄëCD3 + IL‚Äë2 for each perturbation.\\n\\n---\\n\\n## 3. Key biological modules to target\\n\\nTo maximize perturbation of exhaustion/TCR signaling balance:\\n\\n1. **Core exhaustion transcription factors / epigenetic architects**\\n   - TOX/TOX2, NR4A family, BATF/IRF4, NFAT family, EOMES/T‚Äëbet, epigenetic writers/erasers.\\n\\n2. **Coinhibitory receptors & their adaptors**\\n   - PDCD1, CTLA4, LAG3, HAVCR2, TIGIT, etc.\\n   - SHP1/SHP2, CBL family ubiquitin ligases, CSK.\\n\\n3. **TCR proximal and co‚Äëstimulatory signaling**\\n   - CD3‚ÄëITAM adaptor ZAP70, LCK, LAT, GRB2, SOS1, PLCG1, PI3K, AKT, mTOR.\\n\\n4. **Cytokine / survival pathway integration**\\n   - JAK‚ÄëSTAT for IL‚Äë2 (JAK1, JAK3, STAT5A/B), common Œ≥ chain (IL2RG).\\n   - Negative regulators of JAK‚ÄëSTAT (SOCS family, CISH, PTPN2).\\n\\n5. **Metabolic and stress signaling controlling exhaustion**\\n   - mTORC1, AMPK (PRKAA1/2), HIF1A, VHL, PD‚Äë1‚ÄìPI3K axis.\\n\\nYou only have 32 slots, so the list balances:\\n- Direct **exhaustion enforcers**\\n- **Coinhibitory receptors** and their downstream phosphatases/ubiquitin ligases\\n- **Positive TCR signaling components** (whose deletion collapses signaling and might ‚Äúablate‚Äù the difference)\\n- **Integrators** of chronic TCR + IL‚Äë2 ‚Üí exhaustion.\\n\\n---\\n\\n## 4. Proposed 32‚Äëgene CRISPR mini‚Äëlibrary\\n\\nBelow is a curated list of 32 genes, grouped by function. For each, I note expected qualitative effect on chronic TCR signaling and/or exhaustion when **knocked out** in CD8 T cells.\\n\\n### A. Canonical exhaustion TFs and transcriptional regulators (10)\\n\\n1. **TOX**  \\n   - Master regulator of CD8 T‚Äëcell exhaustion; enforces exhausted epigenetic and transcriptional state.\\n   - KO: expected to *prevent or attenuate exhaustion*, preserve stronger TCR signaling and effector function under chronic stimulation.\\n\\n2. **TOX2**  \\n   - Cooperates with TOX; contributes to exhaustion program.\\n   - KO: similar but somewhat milder effect than TOX KO; enhances functional resilience to chronic stimulation.\\n\\n3. **NR4A1**  \\n   - Orphan nuclear receptor induced by chronic TCR; promotes exhaustion and PD‚Äë1 expression.\\n   - KO (alone or with NR4A2/3): reduces exhaustion markers, boosts effector function under chronic signaling.\\n\\n4. **NR4A2**  \\n   - Redundant/overlapping with NR4A1/3 in exhaustion.\\n   - KO: shifts balance away from tolerance/exhaustion, likely maintains higher NFAT/NF‚ÄëŒ∫B‚Äëdriven responses.\\n\\n5. **NR4A3**  \\n   - Third NR4A family member; combined NR4A1/2/3 KO reported to dramatically reinvigorate T cells in chronic antigen settings.\\n   - KO: strongly perturbs exhaustion phenotype.\\n\\n6. **BATF**  \\n   - AP‚Äë1 family TF; contributes to chronic activation and exhaustion differentiation with IRF4.\\n   - KO: expected to alter chronic TCR transcriptional output, potentially reducing exhaustion; may also impair effector differentiation (interesting bidirectional effect).\\n\\n7. **IRF4**  \\n   - TCR signal strength sensor; high, sustained IRF4 promotes terminal exhaustion and effector programs in a dose‚Äëdependent manner.\\n   - KO: reduces chronic TCR signal translation into exhaustion; also compromises effector function‚Äîhighly informative node.\\n\\n8. **NFATC1**  \\n   - Major NFAT isoform in T cells; chronic NFAT activity without AP‚Äë1 drives exhaustion program.\\n   - KO: reduces exhaustion induction but also reduces TCR‚Äëdriven transcription in general; will strongly affect NFAT‚Äëreporter readouts.\\n\\n9. **NFATC2**  \\n   - Additional NFAT isoform; contributes to chronic TCR transcriptional response.\\n   - KO: modulates NFAT signaling amplitude and exhaustion; combined with NFATC1 particularly powerful.\\n\\n10. **EOMES**  \\n    - T‚Äëbox TF; high EOMES often seen in progenitor exhausted cells, balances with TBX21 (T‚Äëbet).\\n    - KO: can skew differentiation toward T‚Äëbet‚Äìhigh effector vs terminal exhaustion; will likely shift functional response under chronic stimulation.\\n\\n---\\n\\n### B. Coinhibitory receptors and checkpoint molecules (8)\\n\\n11. **PDCD1 (PD‚Äë1)**  \\n    - Canonical exhaustion marker and inhibitory receptor; recruits SHP2 to dampen TCR‚ÄëCD28‚ÄëPI3K signaling.\\n    - KO: prevents PD‚Äë1‚Äìmediated inhibition; amplifies TCR signaling under chronic anti‚ÄëCD3 + IL‚Äë2, increasing reporter and cytokine output.\\n\\n12. **CTLA4**  \\n    - Competes with CD28 for CD80/CD86; dampens co‚Äëstimulation.\\n    - KO: enhances co‚Äëstimulation and likely TCR signaling; especially evident in chronic activation conditions.\\n\\n13. **LAG3**  \\n    - Co‚Äëinhibitory receptor binding MHC‚ÄëII; associated with exhausted phenotype.\\n    - KO: reduces inhibitory signaling; augments chronic TCR output and effector function.\\n\\n14. **HAVCR2 (TIM‚Äë3)**  \\n    - Coinhibitory receptor linked to terminal exhaustion and dysfunctional T cells.\\n    - KO: may preserve function in chronically stimulated cells, especially at late time points.\\n\\n15. **TIGIT**  \\n    - Competes with CD226 for CD155/PVR; suppresses signaling via ITIM/ITSM motifs.\\n    - KO: predicted to preserve more robust signaling and cytokine production under chronic stimulation.\\n\\n16. **CD244 (2B4)**  \\n    - SLAM family receptor; can be activating or inhibitory, but in exhausted CD8 T cells tends toward inhibitory roles.\\n    - KO: expected to enhance function and change chronic vs acute signaling relationship.\\n\\n17. **CD160**  \\n    - Another coinhibitory receptor upregulated on chronically stimulated CD8 T cells.\\n    - KO: reduces inhibitory tone, may increase chronic TCR signaling and effector function.\\n\\n18. **CD5**  \\n    - Negative regulator of TCR signaling threshold; tunes TCR sensitivity.\\n    - KO: lowers activation threshold, increases signaling amplitude under both acute and chronic conditions, potentially exaggerating chronic differences.\\n\\n---\\n\\n### C. Phosphatases, ubiquitin ligases, and proximal negative regulators (7)\\n\\n19. **PTPN11 (SHP2)**  \\n    - Recruited by PD‚Äë1 and other ITIM/ITSM receptors; directly dephosphorylates TCR signaling components.\\n    - KO: reduces checkpoint receptor inhibitory capacity, strongly enhances TCR signaling particularly in chronic condition.\\n\\n20. **PTPN6 (SHP1)**  \\n    - Cytoplasmic phosphatase acting on multiple ITAM‚Äëassociated kinases and adaptors.\\n    - KO: heightened TCR signaling; may sensitize cells to both acute and chronic stimulation; profound change in reporter readouts.\\n\\n21. **CSK**  \\n    - Negative regulator of Src family kinases (e.g., LCK); phosphorylates inhibitory tyrosine residues.\\n    - KO: hyperactivates LCK ‚Üí stronger TCR signaling, but may induce activation‚Äëinduced cell death under chronic stimulation; very strong perturbation.\\n\\n22. **CBLB**  \\n    - E3 ubiquitin ligase; negative regulator of TCR and co‚Äëstimulatory signals.\\n    - KO: sustains signaling and proliferation under suboptimal stimulation; expected to strongly alter chronic vs acute TCR responses.\\n\\n23. **ITCH**  \\n    - HECT E3 ligase; regulates signaling adaptors and transcription factors downstream of TCR.\\n    - KO: may stabilize positive signaling components; increases TCR signaling under chronic conditions.\\n\\n24. **SOCS1**  \\n    - Negative regulator of cytokine receptor JAK‚ÄëSTAT (including IL‚Äë2R); also influences TCR‚Äëdriven responses indirectly.\\n    - KO: increases IL‚Äë2‚ÄìSTAT5 signaling, potentially counters exhaustion by supporting survival/proliferation under chronic TCR.\\n\\n25. **CISH**  \\n    - SOCS family member (Cytokine Inducible SH2‚Äëcontaining protein); directly inhibits IL‚Äë2 and IL‚Äë15 signaling.\\n    - KO: enhances IL‚Äë2 responsiveness; in chronic stimulation this may preserve functional competence, increasing differential signaling.\\n\\n---\\n\\n### D. TCR and IL‚Äë2 pathway core signaling nodes (7)\\n\\n26. **LCP2 (SLP‚Äë76)**  \\n    - Central adaptor in TCR signaling (LAT‚ÄìSLP‚Äë76 signalosome).\\n    - KO: dramatically reduces TCR signaling (NFAT/NF‚ÄëŒ∫B), essentially abrogates response to anti‚ÄëCD3; minimal difference between acute and chronic because signaling collapses‚Äîimportant negative control for TCR dependency and maximum suppression.\\n\\n27. **LAT**  \\n    - Membrane adaptor that recruits GRB2, GADS, PLCŒ≥1, etc.\\n    - KO: similar to LCP2 loss; near‚Äëcomplete shutdown of TCR proximal signaling; provides maximal ‚Äúon‚Äëpathway loss-of-function‚Äù reference.\\n\\n28. **PLCG1**  \\n    - PLCŒ≥1; generates IP3/DAG downstream of LAT, essential for Ca¬≤‚Å∫ flux ‚Üí NFAT activation.\\n    - KO: strongly decreases NFAT and NF‚ÄëŒ∫B activation; great for mapping the dependence of your TCR reporter on the canonical pathway.\\n\\n29. **PIK3CD (p110Œ¥)**  \\n    - Catalytic subunit of PI3KŒ¥; dominant in T cells; controls AKT‚ÄìmTOR downstream of TCR/CD28.\\n    - KO: blunts PI3K‚ÄìAKT‚ÄìmTOR; can reduce effector differentiation and affect exhaustion; strong perturbation in chronic condition.\\n\\n30. **AKT1**  \\n    - Central kinase downstream of PI3K; integrates TCR/CD28 and cytokine signals.\\n    - KO: impairs survival, metabolism, and effector functions; may promote memory-like features and modulate exhaustion phenotype under chronic TCR + IL‚Äë2.\\n\\n31. **IL2RG (common Œ≥ chain)**  \\n    - Shared component of IL‚Äë2, IL‚Äë7, IL‚Äë15, etc. receptors.\\n    - KO: abrogates IL‚Äë2 signaling in both conditions; serves as a maximal perturbation for IL‚Äë2 dependence, clarifies interplay between cytokine and TCR inputs.\\n\\n32. **STAT5B**  \\n    - Key transcription factor downstream of IL‚Äë2R.\\n    - KO: diminishes IL‚Äë2 signaling; alters survival/proliferation balance, likely affecting how chronic TCR drives exhaustion vs deletion; highly informative IL‚Äë2‚Äëaxis perturbation.\\n\\n---\\n\\n## 5. How these 32 genes maximize perturbation of the phenotype\\n\\nThis set is crafted to create **large, interpretable shifts** in TCR signaling outputs:\\n\\n- **Direct exhaustion enforcers (TOX, TOX2, NR4A1/2/3, BATF, IRF4, NFATC1/2, EOMES)**  \\n  ‚Üí Their KO should *block or reshape* the exhaustion program, resulting in:\\n  - Higher NFAT/NF‚ÄëŒ∫B reporter signal\\n  - Lower PD‚Äë1/TIM‚Äë3/TOX expression\\n  - Sustained cytokine output in chronic anti‚ÄëCD3 + IL‚Äë2 vs control.\\n\\n- **Checkpoint receptors & proximal inhibitory machinery (PDCD1, CTLA4, LAG3, HAVCR2, TIGIT, CD244, CD160, CD5, PTPN11, PTPN6, CSK, CBLB, ITCH, SOCS1, CISH)**  \\n  ‚Üí Their KO removes **brakes on signaling**, especially evident under chronic stimulation where these brakes are normally engaged. You expect:\\n  - Increased TCR signaling amplitude in chronic vs acute\\n  - Altered shape of dose‚Äìresponse curves to anti‚ÄëCD3\\n  - Possible rescue of function in otherwise exhausted cells.\\n\\n- **Core TCR/IL‚Äë2 signalosome components (LCP2, LAT, PLCG1, PIK3CD, AKT1, IL2RG, STAT5B)**  \\n  ‚Üí Their KO effectively **rewires the input‚Äìoutput relationship**:\\n  - Some (LCP2, LAT, PLCG1) collapse TCR signaling: minimal reporter change even under strong anti‚ÄëCD3.\\n  - Others (PIK3CD, AKT1) preferentially tune metabolic and survival arms that are critical for chronic responses.\\n  - IL2RG and STAT5B mutations decouple IL‚Äë2 effects, revealing which aspects of exhaustion depend on IL‚Äë2‚ÄìSTAT5 vs TCR‚ÄìNFAT.\\n\\nTogether, you end up with a **diverse, mechanistically rich set of perturbations** that will:\\n- Produce large dynamic range in TCR signaling measures.\\n- Differentiate modules that regulate **acute activation** vs **chronic exhaustion**.\\n- Provide strong positive and negative controls for both TCR and IL‚Äë2 axes.\\n\\n---\\n\\n## 6. Practical ‚Äúmini‚Äëscreen‚Äù usage\\n\\nTo ‚Äúexperience‚Äù the screen with this 32‚Äëgene panel:\\n\\n1. **Library design**\\n   - 3‚Äì4 gRNAs per gene (96‚Äì128 guides total) + 8‚Äì16 non‚Äëtargeting controls and 4‚Äì8 essential gene controls (e.g., RPA3) for QC.\\n   - Use SpCas9 KO in primary CD8 T cells or Jurkat + NFAT‚ÄëGFP.\\n\\n2. **Transduction and selection**\\n   - MOI ~0.3 to favor single integration.\\n   - Puromycin/blasticidin selection to enrich sgRNA‚Äëpositive cells.\\n   - Maintain enough cells for ~500‚Äì1,000√ó coverage per sgRNA if pooled.\\n\\n3. **Stimulation and readout**\\n   - Split cells into:\\n     - IL‚Äë2‚Äëonly arm\\n     - Anti‚ÄëCD3 + IL‚Äë2 arm (sustained stimulation)\\n   - After defined timepoints (e.g., day 3, 7, 14), measure:\\n     - NFAT‚ÄëGFP / NF‚ÄëŒ∫B‚ÄëGFP MFI (flow)\\n     - PD‚Äë1, TOX, TIM‚Äë3 surface/intracellular staining\\n     - Cytokines (IFN‚ÄëŒ≥, TNF, IL‚Äë2) by ELISA/ICS.\\n\\n4. **Analysis**\\n   - For each gene, compute:\\n     - ŒîTCR_signal = (chronic condition readout ‚Äì acute condition readout) for KO vs control.\\n   - Genes with largest deviation in ŒîTCR_signal (positive or negative) are top regulators of exhaustion vs sustained function.\\n\\n5. **Follow‚Äëup**\\n   - Deep phenotyping (transcriptomics, ATAC‚Äëseq) of the most extreme hits (e.g., TOX‚ÄëKO, NR4A‚Äëtriple KO, PDCD1‚ÄëKO, PTPN11‚ÄëKO, LCP2‚ÄëKO) to delineate pathways.\\n\\n---\\n\\nIf you‚Äôd like, I can next:\\n- Suggest specific CRISPR sgRNA design strategy for these 32 targets (using the sgRNA Design Guide and CRISPick approach in your environment).\\n- Propose concrete readouts (antibody panels, reporter constructs) and a basic analysis pipeline (including statistical comparisons for an arrayed 96‚Äëwell mini‚Äëscreen).  \\n</solution>\", \"tool_calls\": [], \"usage_metadata\": null, \"additional_kwargs\": {}, \"response_metadata\": {}, \"invalid_tool_calls\": []}], \"next_step\": \"end\"}\n\n[{'text': '<solution>\\n1. [‚úì] Clarify the biological goal and constraints based on user prompt  \\n2. [‚úì] Define a conceptual CRISPR screen design (cell model, library, readout, conditions)  \\n3. [‚úì] Identify pathways and gene classes most likely to regulate T cell exhaustion and TCR signaling  \\n4. [‚úì] Propose a realistic CRISPR screening strategy (pooled vs arrayed; KO vs CRISPRi/a; controls)  \\n5. [‚úì] Narrow down to a focused list of 32 high-priority genes predicted to maximally perturb TCR signaling differences between acute vs chronic stimulation  \\n6. [‚úì] For each gene, briefly justify inclusion and expected direction of effect  \\n7. [‚úì] Summarize how these 32-gene set would be used in a ‚Äúmini-screen‚Äù and how to interpret outcomes  \\n\\n---\\n\\nBelow I both (a) outline how you would design and interpret the screen, and (b) give a concrete, curated list of 32 genes with rationale.\\n\\n---\\n\\n## 1. Biological objective restated\\n\\nYou want to:\\n\\n- Perform a CRISPR screen in T cells  \\n- Compare **TCR signaling output** under:\\n  - **Acute condition:** IL‚Äë2 only (minimal TCR engagement; survival/proliferation cue)\\n  - **Chronic condition:** anti‚ÄëCD3 + IL‚Äë2 (persistent TCR signaling ‚Üí exhaustion-like state)\\n- Readout: A measure of **TCR signaling strength and/or exhaustion state** that changes between these two conditions (e.g., NFAT or NF‚ÄëŒ∫B reporter, CD69/PD‚Äë1/TOX expression, phospho‚ÄëZAP70/ERK, or functional cytokine output)\\n- Design a focused library of **32 genes** whose perturbation (KO or CRISPRi/a) is expected to maximize the difference in TCR signaling between acute and chronic conditions (i.e., strongly modulate exhaustion).\\n\\nKey idea: choose genes that are:\\n- Core exhaustion TFs and epigenetic regulators  \\n- Coinhibitory receptors & proximal signaling nodes  \\n- Cytokine pathway modulators that interact with IL‚Äë2 and chronic TCR signaling  \\n- A few positive regulators to ‚Äúbreak‚Äù exhaustion and a few brakes to enforce it  \\n\\n---\\n\\n## 2. Conceptual CRISPR screen design\\n\\n### Cell model\\n- **Primary human CD8+ T cells** from healthy donors, or an exhaustion-prone T‚Äëcell line (e.g., Jurkat with appropriate reporter) if feasibility is an issue.\\n- Engineering:\\n  - Lentiviral Cas9 or CRISPRi (dCas9-KRAB) line\\n  - Introduce TCR signaling reporter (e.g., NFAT‚ÄëGFP, NF‚ÄëŒ∫B‚ÄëGFP, or IL‚Äë2 promoter‚ÄìGFP).\\n\\n### Stimulation conditions\\n\\n1. **Acute-like condition (‚ÄúIL‚Äë2 only‚Äù)**\\n   - Cells cultured in IL‚Äë2 (e.g., 50‚Äì100 IU/mL) without continuous TCR engagement.\\n   - ‚ÄúBaseline‚Äù TCR signaling low; IL‚Äë2R‚ÄìSTAT5 pathway active.\\n\\n2. **Chronic-like condition (‚Äúanti‚ÄëCD3 + IL‚Äë2‚Äù)**\\n   - Plate-bound or bead-conjugated anti‚ÄëCD3 plus IL‚Äë2 for several days to weeks.\\n   - Sustained TCR signal drives:\\n     - PD‚Äë1, LAG‚Äë3, TIM‚Äë3, CTLA‚Äë4, TIGIT upregulation\\n     - Transcriptional and epigenetic program: TOX, NR4A family, NFAT with low AP‚Äë1, BATF/IRF4 changes\\n     - Decreased effector cytokines (IFN‚ÄëŒ≥, TNF) over time.\\n\\n### Readout options (to connect to CRISPR perturbations)\\n\\nExamples for a pooled screen:\\n- **FACS‚Äëbased pooled screen**:\\n  - Reporter: NFAT‚ÄëGFP or NF‚ÄëŒ∫B‚ÄëGFP.\\n  - Sort high vs low GFP under each condition; sequence sgRNAs.\\n  - Differential enrichment reflects genes that change the chronic vs acute ratio of reporter activity.\\n\\n- **Surface exhaustion markers**:\\n  - Label PD‚Äë1, TIM‚Äë3, CD39, etc; sort high vs low PD‚Äë1 and sequence sgRNAs.\\n\\nFor a **32‚Äëgene mini-screen**, an arrayed format is feasible:\\n- Transduce or electroporate 1‚Äì3 gRNAs per gene in 96‚Äëwell plates.\\n- Measure:\\n  - NFAT‚ÄëGFP MFI\\n  - pZAP70 / pERK by phospho‚Äëflow\\n  - PD‚Äë1, TOX, TIM‚Äë3 expression\\n  - Cytokine production (IFN‚ÄëŒ≥, TNF, IL‚Äë2) by ELISA/ICS\\n  - Compare readout between IL‚Äë2 only and anti‚ÄëCD3 + IL‚Äë2 for each perturbation.\\n\\n---\\n\\n## 3. Key biological modules to target\\n\\nTo maximize perturbation of exhaustion/TCR signaling balance:\\n\\n1. **Core exhaustion transcription factors / epigenetic architects**\\n   - TOX/TOX2, NR4A family, BATF/IRF4, NFAT family, EOMES/T‚Äëbet, epigenetic writers/erasers.\\n\\n2. **Coinhibitory receptors & their adaptors**\\n   - PDCD1, CTLA4, LAG3, HAVCR2, TIGIT, etc.\\n   - SHP1/SHP2, CBL family ubiquitin ligases, CSK.\\n\\n3. **TCR proximal and co‚Äëstimulatory signaling**\\n   - CD3‚ÄëITAM adaptor ZAP70, LCK, LAT, GRB2, SOS1, PLCG1, PI3K, AKT, mTOR.\\n\\n4. **Cytokine / survival pathway integration**\\n   - JAK‚ÄëSTAT for IL‚Äë2 (JAK1, JAK3, STAT5A/B), common Œ≥ chain (IL2RG).\\n   - Negative regulators of JAK‚ÄëSTAT (SOCS family, CISH, PTPN2).\\n\\n5. **Metabolic and stress signaling controlling exhaustion**\\n   - mTORC1, AMPK (PRKAA1/2), HIF1A, VHL, PD‚Äë1‚ÄìPI3K axis.\\n\\nYou only have 32 slots, so the list balances:\\n- Direct **exhaustion enforcers**\\n- **Coinhibitory receptors** and their downstream phosphatases/ubiquitin ligases\\n- **Positive TCR signaling components** (whose deletion collapses signaling and might ‚Äúablate‚Äù the difference)\\n- **Integrators** of chronic TCR + IL‚Äë2 ‚Üí exhaustion.\\n\\n---\\n\\n## 4. Proposed 32‚Äëgene CRISPR mini‚Äëlibrary\\n\\nBelow is a curated list of 32 genes, grouped by function. For each, I note expected qualitative effect on chronic TCR signaling and/or exhaustion when **knocked out** in CD8 T cells.\\n\\n### A. Canonical exhaustion TFs and transcriptional regulators (10)\\n\\n1. **TOX**  \\n   - Master regulator of CD8 T‚Äëcell exhaustion; enforces exhausted epigenetic and transcriptional state.\\n   - KO: expected to *prevent or attenuate exhaustion*, preserve stronger TCR signaling and effector function under chronic stimulation.\\n\\n2. **TOX2**  \\n   - Cooperates with TOX; contributes to exhaustion program.\\n   - KO: similar but somewhat milder effect than TOX KO; enhances functional resilience to chronic stimulation.\\n\\n3. **NR4A1**  \\n   - Orphan nuclear receptor induced by chronic TCR; promotes exhaustion and PD‚Äë1 expression.\\n   - KO (alone or with NR4A2/3): reduces exhaustion markers, boosts effector function under chronic signaling.\\n\\n4. **NR4A2**  \\n   - Redundant/overlapping with NR4A1/3 in exhaustion.\\n   - KO: shifts balance away from tolerance/exhaustion, likely maintains higher NFAT/NF‚ÄëŒ∫B‚Äëdriven responses.\\n\\n5. **NR4A3**  \\n   - Third NR4A family member; combined NR4A1/2/3 KO reported to dramatically reinvigorate T cells in chronic antigen settings.\\n   - KO: strongly perturbs exhaustion phenotype.\\n\\n6. **BATF**  \\n   - AP‚Äë1 family TF; contributes to chronic activation and exhaustion differentiation with IRF4.\\n   - KO: expected to alter chronic TCR transcriptional output, potentially reducing exhaustion; may also impair effector differentiation (interesting bidirectional effect).\\n\\n7. **IRF4**  \\n   - TCR signal strength sensor; high, sustained IRF4 promotes terminal exhaustion and effector programs in a dose‚Äëdependent manner.\\n   - KO: reduces chronic TCR signal translation into exhaustion; also compromises effector function‚Äîhighly informative node.\\n\\n8. **NFATC1**  \\n   - Major NFAT isoform in T cells; chronic NFAT activity without AP‚Äë1 drives exhaustion program.\\n   - KO: reduces exhaustion induction but also reduces TCR‚Äëdriven transcription in general; will strongly affect NFAT‚Äëreporter readouts.\\n\\n9. **NFATC2**  \\n   - Additional NFAT isoform; contributes to chronic TCR transcriptional response.\\n   - KO: modulates NFAT signaling amplitude and exhaustion; combined with NFATC1 particularly powerful.\\n\\n10. **EOMES**  \\n    - T‚Äëbox TF; high EOMES often seen in progenitor exhausted cells, balances with TBX21 (T‚Äëbet).\\n    - KO: can skew differentiation toward T‚Äëbet‚Äìhigh effector vs terminal exhaustion; will likely shift functional response under chronic stimulation.\\n\\n---\\n\\n### B. Coinhibitory receptors and checkpoint molecules (8)\\n\\n11. **PDCD1 (PD‚Äë1)**  \\n    - Canonical exhaustion marker and inhibitory receptor; recruits SHP2 to dampen TCR‚ÄëCD28‚ÄëPI3K signaling.\\n    - KO: prevents PD‚Äë1‚Äìmediated inhibition; amplifies TCR signaling under chronic anti‚ÄëCD3 + IL‚Äë2, increasing reporter and cytokine output.\\n\\n12. **CTLA4**  \\n    - Competes with CD28 for CD80/CD86; dampens co‚Äëstimulation.\\n    - KO: enhances co‚Äëstimulation and likely TCR signaling; especially evident in chronic activation conditions.\\n\\n13. **LAG3**  \\n    - Co‚Äëinhibitory receptor binding MHC‚ÄëII; associated with exhausted phenotype.\\n    - KO: reduces inhibitory signaling; augments chronic TCR output and effector function.\\n\\n14. **HAVCR2 (TIM‚Äë3)**  \\n    - Coinhibitory receptor linked to terminal exhaustion and dysfunctional T cells.\\n    - KO: may preserve function in chronically stimulated cells, especially at late time points.\\n\\n15. **TIGIT**  \\n    - Competes with CD226 for CD155/PVR; suppresses signaling via ITIM/ITSM motifs.\\n    - KO: predicted to preserve more robust signaling and cytokine production under chronic stimulation.\\n\\n16. **CD244 (2B4)**  \\n    - SLAM family receptor; can be activating or inhibitory, but in exhausted CD8 T cells tends toward inhibitory roles.\\n    - KO: expected to enhance function and change chronic vs acute signaling relationship.\\n\\n17. **CD160**  \\n    - Another coinhibitory receptor upregulated on chronically stimulated CD8 T cells.\\n    - KO: reduces inhibitory tone, may increase chronic TCR signaling and effector function.\\n\\n18. **CD5**  \\n    - Negative regulator of TCR signaling threshold; tunes TCR sensitivity.\\n    - KO: lowers activation threshold, increases signaling amplitude under both acute and chronic conditions, potentially exaggerating chronic differences.\\n\\n---\\n\\n### C. Phosphatases, ubiquitin ligases, and proximal negative regulators (7)\\n\\n19. **PTPN11 (SHP2)**  \\n    - Recruited by PD‚Äë1 and other ITIM/ITSM receptors; directly dephosphorylates TCR signaling components.\\n    - KO: reduces checkpoint receptor inhibitory capacity, strongly enhances TCR signaling particularly in chronic condition.\\n\\n20. **PTPN6 (SHP1)**  \\n    - Cytoplasmic phosphatase acting on multiple ITAM‚Äëassociated kinases and adaptors.\\n    - KO: heightened TCR signaling; may sensitize cells to both acute and chronic stimulation; profound change in reporter readouts.\\n\\n21. **CSK**  \\n    - Negative regulator of Src family kinases (e.g., LCK); phosphorylates inhibitory tyrosine residues.\\n    - KO: hyperactivates LCK ‚Üí stronger TCR signaling, but may induce activation‚Äëinduced cell death under chronic stimulation; very strong perturbation.\\n\\n22. **CBLB**  \\n    - E3 ubiquitin ligase; negative regulator of TCR and co‚Äëstimulatory signals.\\n    - KO: sustains signaling and proliferation under suboptimal stimulation; expected to strongly alter chronic vs acute TCR responses.\\n\\n23. **ITCH**  \\n    - HECT E3 ligase; regulates signaling adaptors and transcription factors downstream of TCR.\\n    - KO: may stabilize positive signaling components; increases TCR signaling under chronic conditions.\\n\\n24. **SOCS1**  \\n    - Negative regulator of cytokine receptor JAK‚ÄëSTAT (including IL‚Äë2R); also influences TCR‚Äëdriven responses indirectly.\\n    - KO: increases IL‚Äë2‚ÄìSTAT5 signaling, potentially counters exhaustion by supporting survival/proliferation under chronic TCR.\\n\\n25. **CISH**  \\n    - SOCS family member (Cytokine Inducible SH2‚Äëcontaining protein); directly inhibits IL‚Äë2 and IL‚Äë15 signaling.\\n    - KO: enhances IL‚Äë2 responsiveness; in chronic stimulation this may preserve functional competence, increasing differential signaling.\\n\\n---\\n\\n### D. TCR and IL‚Äë2 pathway core signaling nodes (7)\\n\\n26. **LCP2 (SLP‚Äë76)**  \\n    - Central adaptor in TCR signaling (LAT‚ÄìSLP‚Äë76 signalosome).\\n    - KO: dramatically reduces TCR signaling (NFAT/NF‚ÄëŒ∫B), essentially abrogates response to anti‚ÄëCD3; minimal difference between acute and chronic because signaling collapses‚Äîimportant negative control for TCR dependency and maximum suppression.\\n\\n27. **LAT**  \\n    - Membrane adaptor that recruits GRB2, GADS, PLCŒ≥1, etc.\\n    - KO: similar to LCP2 loss; near‚Äëcomplete shutdown of TCR proximal signaling; provides maximal ‚Äúon‚Äëpathway loss-of-function‚Äù reference.\\n\\n28. **PLCG1**  \\n    - PLCŒ≥1; generates IP3/DAG downstream of LAT, essential for Ca¬≤‚Å∫ flux ‚Üí NFAT activation.\\n    - KO: strongly decreases NFAT and NF‚ÄëŒ∫B activation; great for mapping the dependence of your TCR reporter on the canonical pathway.\\n\\n29. **PIK3CD (p110Œ¥)**  \\n    - Catalytic subunit of PI3KŒ¥; dominant in T cells; controls AKT‚ÄìmTOR downstream of TCR/CD28.\\n    - KO: blunts PI3K‚ÄìAKT‚ÄìmTOR; can reduce effector differentiation and affect exhaustion; strong perturbation in chronic condition.\\n\\n30. **AKT1**  \\n    - Central kinase downstream of PI3K; integrates TCR/CD28 and cytokine signals.\\n    - KO: impairs survival, metabolism, and effector functions; may promote memory-like features and modulate exhaustion phenotype under chronic TCR + IL‚Äë2.\\n\\n31. **IL2RG (common Œ≥ chain)**  \\n    - Shared component of IL‚Äë2, IL‚Äë7, IL‚Äë15, etc. receptors.\\n    - KO: abrogates IL‚Äë2 signaling in both conditions; serves as a maximal perturbation for IL‚Äë2 dependence, clarifies interplay between cytokine and TCR inputs.\\n\\n32. **STAT5B**  \\n    - Key transcription factor downstream of IL‚Äë2R.\\n    - KO: diminishes IL‚Äë2 signaling; alters survival/proliferation balance, likely affecting how chronic TCR drives exhaustion vs deletion; highly informative IL‚Äë2‚Äëaxis perturbation.\\n\\n---\\n\\n## 5. How these 32 genes maximize perturbation of the phenotype\\n\\nThis set is crafted to create **large, interpretable shifts** in TCR signaling outputs:\\n\\n- **Direct exhaustion enforcers (TOX, TOX2, NR4A1/2/3, BATF, IRF4, NFATC1/2, EOMES)**  \\n  ‚Üí Their KO should *block or reshape* the exhaustion program, resulting in:\\n  - Higher NFAT/NF‚ÄëŒ∫B reporter signal\\n  - Lower PD‚Äë1/TIM‚Äë3/TOX expression\\n  - Sustained cytokine output in chronic anti‚ÄëCD3 + IL‚Äë2 vs control.\\n\\n- **Checkpoint receptors & proximal inhibitory machinery (PDCD1, CTLA4, LAG3, HAVCR2, TIGIT, CD244, CD160, CD5, PTPN11, PTPN6, CSK, CBLB, ITCH, SOCS1, CISH)**  \\n  ‚Üí Their KO removes **brakes on signaling**, especially evident under chronic stimulation where these brakes are normally engaged. You expect:\\n  - Increased TCR signaling amplitude in chronic vs acute\\n  - Altered shape of dose‚Äìresponse curves to anti‚ÄëCD3\\n  - Possible rescue of function in otherwise exhausted cells.\\n\\n- **Core TCR/IL‚Äë2 signalosome components (LCP2, LAT, PLCG1, PIK3CD, AKT1, IL2RG, STAT5B)**  \\n  ‚Üí Their KO effectively **rewires the input‚Äìoutput relationship**:\\n  - Some (LCP2, LAT, PLCG1) collapse TCR signaling: minimal reporter change even under strong anti‚ÄëCD3.\\n  - Others (PIK3CD, AKT1) preferentially tune metabolic and survival arms that are critical for chronic responses.\\n  - IL2RG and STAT5B mutations decouple IL‚Äë2 effects, revealing which aspects of exhaustion depend on IL‚Äë2‚ÄìSTAT5 vs TCR‚ÄìNFAT.\\n\\nTogether, you end up with a **diverse, mechanistically rich set of perturbations** that will:\\n- Produce large dynamic range in TCR signaling measures.\\n- Differentiate modules that regulate **acute activation** vs **chronic exhaustion**.\\n- Provide strong positive and negative controls for both TCR and IL‚Äë2 axes.\\n\\n---\\n\\n## 6. Practical ‚Äúmini‚Äëscreen‚Äù usage\\n\\nTo ‚Äúexperience‚Äù the screen with this 32‚Äëgene panel:\\n\\n1. **Library design**\\n   - 3‚Äì4 gRNAs per gene (96‚Äì128 guides total) + 8‚Äì16 non‚Äëtargeting controls and 4‚Äì8 essential gene controls (e.g., RPA3) for QC.\\n   - Use SpCas9 KO in primary CD8 T cells or Jurkat + NFAT‚ÄëGFP.\\n\\n2. **Transduction and selection**\\n   - MOI ~0.3 to favor single integration.\\n   - Puromycin/blasticidin selection to enrich sgRNA‚Äëpositive cells.\\n   - Maintain enough cells for ~500‚Äì1,000√ó coverage per sgRNA if pooled.\\n\\n3. **Stimulation and readout**\\n   - Split cells into:\\n     - IL‚Äë2‚Äëonly arm\\n     - Anti‚ÄëCD3 + IL‚Äë2 arm (sustained stimulation)\\n   - After defined timepoints (e.g., day 3, 7, 14), measure:\\n     - NFAT‚ÄëGFP / NF‚ÄëŒ∫B‚ÄëGFP MFI (flow)\\n     - PD‚Äë1, TOX, TIM‚Äë3 surface/intracellular staining\\n     - Cytokines (IFN‚ÄëŒ≥, TNF, IL‚Äë2) by ELISA/ICS.\\n\\n4. **Analysis**\\n   - For each gene, compute:\\n     - ŒîTCR_signal = (chronic condition readout ‚Äì acute condition readout) for KO vs control.\\n   - Genes with largest deviation in ŒîTCR_signal (positive or negative) are top regulators of exhaustion vs sustained function.\\n\\n5. **Follow‚Äëup**\\n   - Deep phenotyping (transcriptomics, ATAC‚Äëseq) of the most extreme hits (e.g., TOX‚ÄëKO, NR4A‚Äëtriple KO, PDCD1‚ÄëKO, PTPN11‚ÄëKO, LCP2‚ÄëKO) to delineate pathways.\\n\\n---\\n\\nIf you‚Äôd like, I can next:\\n- Suggest specific CRISPR sgRNA design strategy for these 32 targets (using the sgRNA Design Guide and CRISPick approach in your environment).\\n- Propose concrete readouts (antibody panels, reporter constructs) and a basic analysis pipeline (including statistical comparisons for an arrayed 96‚Äëwell mini‚Äëscreen).  \\n</solution>', 'type': 'text', 'annotations': []}]\n\nObservation:\nend\n</think>\n\n<solution>\n1. [‚úì] Clarify the biological goal and constraints based on user prompt  \n2. [‚úì] Define a conceptual CRISPR screen design (cell model, library, readout, conditions)  \n3. [‚úì] Identify pathways and gene classes most likely to regulate T cell exhaustion and TCR signaling  \n4. [‚úì] Propose a realistic CRISPR screening strategy (pooled vs arrayed; KO vs CRISPRi/a; controls)  \n5. [‚úì] Narrow down to a focused list of 32 high-priority genes predicted to maximally perturb TCR signaling differences between acute vs chronic stimulation  \n6. [‚úì] For each gene, briefly justify inclusion and expected direction of effect  \n7. [‚úì] Summarize how these 32-gene set would be used in a ‚Äúmini-screen‚Äù and how to interpret outcomes  \n\n---\n\nBelow I both (a) outline how you would design and interpret the screen, and (b) give a concrete, curated list of 32 genes with rationale.\n\n---\n\n## 1. Biological objective restated\n\nYou want to:\n\n- Perform a CRISPR screen in T cells  \n- Compare **TCR signaling output** under:\n  - **Acute condition:** IL‚Äë2 only (minimal TCR engagement; survival/proliferation cue)\n  - **Chronic condition:** anti‚ÄëCD3 + IL‚Äë2 (persistent TCR signaling ‚Üí exhaustion-like state)\n- Readout: A measure of **TCR signaling strength and/or exhaustion state** that changes between these two conditions (e.g., NFAT or NF‚ÄëŒ∫B reporter, CD69/PD‚Äë1/TOX expression, phospho‚ÄëZAP70/ERK, or functional cytokine output)\n- Design a focused library of **32 genes** whose perturbation (KO or CRISPRi/a) is expected to maximize the difference in TCR signaling between acute and chronic conditions (i.e., strongly modulate exhaustion).\n\nKey idea: choose genes that are:\n- Core exhaustion TFs and epigenetic regulators  \n- Coinhibitory receptors & proximal signaling nodes  \n- Cytokine pathway modulators that interact with IL‚Äë2 and chronic TCR signaling  \n- A few positive regulators to ‚Äúbreak‚Äù exhaustion and a few brakes to enforce it  \n\n---\n\n## 2. Conceptual CRISPR screen design\n\n### Cell model\n- **Primary human CD8+ T cells** from healthy donors, or an exhaustion-prone T‚Äëcell line (e.g., Jurkat with appropriate reporter) if feasibility is an issue.\n- Engineering:\n  - Lentiviral Cas9 or CRISPRi (dCas9-KRAB) line\n  - Introduce TCR signaling reporter (e.g., NFAT‚ÄëGFP, NF‚ÄëŒ∫B‚ÄëGFP, or IL‚Äë2 promoter‚ÄìGFP).\n\n### Stimulation conditions\n\n1. **Acute-like condition (‚ÄúIL‚Äë2 only‚Äù)**\n   - Cells cultured in IL‚Äë2 (e.g., 50‚Äì100 IU/mL) without continuous TCR engagement.\n   - ‚ÄúBaseline‚Äù TCR signaling low; IL‚Äë2R‚ÄìSTAT5 pathway active.\n\n2. **Chronic-like condition (‚Äúanti‚ÄëCD3 + IL‚Äë2‚Äù)**\n   - Plate-bound or bead-conjugated anti‚ÄëCD3 plus IL‚Äë2 for several days to weeks.\n   - Sustained TCR signal drives:\n     - PD‚Äë1, LAG‚Äë3, TIM‚Äë3, CTLA‚Äë4, TIGIT upregulation\n     - Transcriptional and epigenetic program: TOX, NR4A family, NFAT with low AP‚Äë1, BATF/IRF4 changes\n     - Decreased effector cytokines (IFN‚ÄëŒ≥, TNF) over time.\n\n### Readout options (to connect to CRISPR perturbations)\n\nExamples for a pooled screen:\n- **FACS‚Äëbased pooled screen**:\n  - Reporter: NFAT‚ÄëGFP or NF‚ÄëŒ∫B‚ÄëGFP.\n  - Sort high vs low GFP under each condition; sequence sgRNAs.\n  - Differential enrichment reflects genes that change the chronic vs acute ratio of reporter activity.\n\n- **Surface exhaustion markers**:\n  - Label PD‚Äë1, TIM‚Äë3, CD39, etc; sort high vs low PD‚Äë1 and sequence sgRNAs.\n\nFor a **32‚Äëgene mini-screen**, an arrayed format is feasible:\n- Transduce or electroporate 1‚Äì3 gRNAs per gene in 96‚Äëwell plates.\n- Measure:\n  - NFAT‚ÄëGFP MFI\n  - pZAP70 / pERK by phospho‚Äëflow\n  - PD‚Äë1, TOX, TIM‚Äë3 expression\n  - Cytokine production (IFN‚ÄëŒ≥, TNF, IL‚Äë2) by ELISA/ICS\n  - Compare readout between IL‚Äë2 only and anti‚ÄëCD3 + IL‚Äë2 for each perturbation.\n\n---\n\n## 3. Key biological modules to target\n\nTo maximize perturbation of exhaustion/TCR signaling balance:\n\n1. **Core exhaustion transcription factors / epigenetic architects**\n   - TOX/TOX2, NR4A family, BATF/IRF4, NFAT family, EOMES/T‚Äëbet, epigenetic writers/erasers.\n\n2. **Coinhibitory receptors & their adaptors**\n   - PDCD1, CTLA4, LAG3, HAVCR2, TIGIT, etc.\n   - SHP1/SHP2, CBL family ubiquitin ligases, CSK.\n\n3. **TCR proximal and co‚Äëstimulatory signaling**\n   - CD3‚ÄëITAM adaptor ZAP70, LCK, LAT, GRB2, SOS1, PLCG1, PI3K, AKT, mTOR.\n\n4. **Cytokine / survival pathway integration**\n   - JAK‚ÄëSTAT for IL‚Äë2 (JAK1, JAK3, STAT5A/B), common Œ≥ chain (IL2RG).\n   - Negative regulators of JAK‚ÄëSTAT (SOCS family, CISH, PTPN2).\n\n5. **Metabolic and stress signaling controlling exhaustion**\n   - mTORC1, AMPK (PRKAA1/2), HIF1A, VHL, PD‚Äë1‚ÄìPI3K axis.\n\nYou only have 32 slots, so the list balances:\n- Direct **exhaustion enforcers**\n- **Coinhibitory receptors** and their downstream phosphatases/ubiquitin ligases\n- **Positive TCR signaling components** (whose deletion collapses signaling and might ‚Äúablate‚Äù the difference)\n- **Integrators** of chronic TCR + IL‚Äë2 ‚Üí exhaustion.\n\n---\n\n## 4. Proposed 32‚Äëgene CRISPR mini‚Äëlibrary\n\nBelow is a curated list of 32 genes, grouped by function. For each, I note expected qualitative effect on chronic TCR signaling and/or exhaustion when **knocked out** in CD8 T cells.\n\n### A. Canonical exhaustion TFs and transcriptional regulators (10)\n\n1. **TOX**  \n   - Master regulator of CD8 T‚Äëcell exhaustion; enforces exhausted epigenetic and transcriptional state.\n   - KO: expected to *prevent or attenuate exhaustion*, preserve stronger TCR signaling and effector function under chronic stimulation.\n\n2. **TOX2**  \n   - Cooperates with TOX; contributes to exhaustion program.\n   - KO: similar but somewhat milder effect than TOX KO; enhances functional resilience to chronic stimulation.\n\n3. **NR4A1**  \n   - Orphan nuclear receptor induced by chronic TCR; promotes exhaustion and PD‚Äë1 expression.\n   - KO (alone or with NR4A2/3): reduces exhaustion markers, boosts effector function under chronic signaling.\n\n4. **NR4A2**  \n   - Redundant/overlapping with NR4A1/3 in exhaustion.\n   - KO: shifts balance away from tolerance/exhaustion, likely maintains higher NFAT/NF‚ÄëŒ∫B‚Äëdriven responses.\n\n5. **NR4A3**  \n   - Third NR4A family member; combined NR4A1/2/3 KO reported to dramatically reinvigorate T cells in chronic antigen settings.\n   - KO: strongly perturbs exhaustion phenotype.\n\n6. **BATF**  \n   - AP‚Äë1 family TF; contributes to chronic activation and exhaustion differentiation with IRF4.\n   - KO: expected to alter chronic TCR transcriptional output, potentially reducing exhaustion; may also impair effector differentiation (interesting bidirectional effect).\n\n7. **IRF4**  \n   - TCR signal strength sensor; high, sustained IRF4 promotes terminal exhaustion and effector programs in a dose‚Äëdependent manner.\n   - KO: reduces chronic TCR signal translation into exhaustion; also compromises effector function‚Äîhighly informative node.\n\n8. **NFATC1**  \n   - Major NFAT isoform in T cells; chronic NFAT activity without AP‚Äë1 drives exhaustion program.\n   - KO: reduces exhaustion induction but also reduces TCR‚Äëdriven transcription in general; will strongly affect NFAT‚Äëreporter readouts.\n\n9. **NFATC2**  \n   - Additional NFAT isoform; contributes to chronic TCR transcriptional response.\n   - KO: modulates NFAT signaling amplitude and exhaustion; combined with NFATC1 particularly powerful.\n\n10. **EOMES**  \n    - T‚Äëbox TF; high EOMES often seen in progenitor exhausted cells, balances with TBX21 (T‚Äëbet).\n    - KO: can skew differentiation toward T‚Äëbet‚Äìhigh effector vs terminal exhaustion; will likely shift functional response under chronic stimulation.\n\n---\n\n### B. Coinhibitory receptors and checkpoint molecules (8)\n\n11. **PDCD1 (PD‚Äë1)**  \n    - Canonical exhaustion marker and inhibitory receptor; recruits SHP2 to dampen TCR‚ÄëCD28‚ÄëPI3K signaling.\n    - KO: prevents PD‚Äë1‚Äìmediated inhibition; amplifies TCR signaling under chronic anti‚ÄëCD3 + IL‚Äë2, increasing reporter and cytokine output.\n\n12. **CTLA4**  \n    - Competes with CD28 for CD80/CD86; dampens co‚Äëstimulation.\n    - KO: enhances co‚Äëstimulation and likely TCR signaling; especially evident in chronic activation conditions.\n\n13. **LAG3**  \n    - Co‚Äëinhibitory receptor binding MHC‚ÄëII; associated with exhausted phenotype.\n    - KO: reduces inhibitory signaling; augments chronic TCR output and effector function.\n\n14. **HAVCR2 (TIM‚Äë3)**  \n    - Coinhibitory receptor linked to terminal exhaustion and dysfunctional T cells.\n    - KO: may preserve function in chronically stimulated cells, especially at late time points.\n\n15. **TIGIT**  \n    - Competes with CD226 for CD155/PVR; suppresses signaling via ITIM/ITSM motifs.\n    - KO: predicted to preserve more robust signaling and cytokine production under chronic stimulation.\n\n16. **CD244 (2B4)**  \n    - SLAM family receptor; can be activating or inhibitory, but in exhausted CD8 T cells tends toward inhibitory roles.\n    - KO: expected to enhance function and change chronic vs acute signaling relationship.\n\n17. **CD160**  \n    - Another coinhibitory receptor upregulated on chronically stimulated CD8 T cells.\n    - KO: reduces inhibitory tone, may increase chronic TCR signaling and effector function.\n\n18. **CD5**  \n    - Negative regulator of TCR signaling threshold; tunes TCR sensitivity.\n    - KO: lowers activation threshold, increases signaling amplitude under both acute and chronic conditions, potentially exaggerating chronic differences.\n\n---\n\n### C. Phosphatases, ubiquitin ligases, and proximal negative regulators (7)\n\n19. **PTPN11 (SHP2)**  \n    - Recruited by PD‚Äë1 and other ITIM/ITSM receptors; directly dephosphorylates TCR signaling components.\n    - KO: reduces checkpoint receptor inhibitory capacity, strongly enhances TCR signaling particularly in chronic condition.\n\n20. **PTPN6 (SHP1)**  \n    - Cytoplasmic phosphatase acting on multiple ITAM‚Äëassociated kinases and adaptors.\n    - KO: heightened TCR signaling; may sensitize cells to both acute and chronic stimulation; profound change in reporter readouts.\n\n21. **CSK**  \n    - Negative regulator of Src family kinases (e.g., LCK); phosphorylates inhibitory tyrosine residues.\n    - KO: hyperactivates LCK ‚Üí stronger TCR signaling, but may induce activation‚Äëinduced cell death under chronic stimulation; very strong perturbation.\n\n22. **CBLB**  \n    - E3 ubiquitin ligase; negative regulator of TCR and co‚Äëstimulatory signals.\n    - KO: sustains signaling and proliferation under suboptimal stimulation; expected to strongly alter chronic vs acute TCR responses.\n\n23. **ITCH**  \n    - HECT E3 ligase; regulates signaling adaptors and transcription factors downstream of TCR.\n    - KO: may stabilize positive signaling components; increases TCR signaling under chronic conditions.\n\n24. **SOCS1**  \n    - Negative regulator of cytokine receptor JAK‚ÄëSTAT (including IL‚Äë2R); also influences TCR‚Äëdriven responses indirectly.\n    - KO: increases IL‚Äë2‚ÄìSTAT5 signaling, potentially counters exhaustion by supporting survival/proliferation under chronic TCR.\n\n25. **CISH**  \n    - SOCS family member (Cytokine Inducible SH2‚Äëcontaining protein); directly inhibits IL‚Äë2 and IL‚Äë15 signaling.\n    - KO: enhances IL‚Äë2 responsiveness; in chronic stimulation this may preserve functional competence, increasing differential signaling.\n\n---\n\n### D. TCR and IL‚Äë2 pathway core signaling nodes (7)\n\n26. **LCP2 (SLP‚Äë76)**  \n    - Central adaptor in TCR signaling (LAT‚ÄìSLP‚Äë76 signalosome).\n    - KO: dramatically reduces TCR signaling (NFAT/NF‚ÄëŒ∫B), essentially abrogates response to anti‚ÄëCD3; minimal difference between acute and chronic because signaling collapses‚Äîimportant negative control for TCR dependency and maximum suppression.\n\n27. **LAT**  \n    - Membrane adaptor that recruits GRB2, GADS, PLCŒ≥1, etc.\n    - KO: similar to LCP2 loss; near‚Äëcomplete shutdown of TCR proximal signaling; provides maximal ‚Äúon‚Äëpathway loss-of-function‚Äù reference.\n\n28. **PLCG1**  \n    - PLCŒ≥1; generates IP3/DAG downstream of LAT, essential for Ca¬≤‚Å∫ flux ‚Üí NFAT activation.\n    - KO: strongly decreases NFAT and NF‚ÄëŒ∫B activation; great for mapping the dependence of your TCR reporter on the canonical pathway.\n\n29. **PIK3CD (p110Œ¥)**  \n    - Catalytic subunit of PI3KŒ¥; dominant in T cells; controls AKT‚ÄìmTOR downstream of TCR/CD28.\n    - KO: blunts PI3K‚ÄìAKT‚ÄìmTOR; can reduce effector differentiation and affect exhaustion; strong perturbation in chronic condition.\n\n30. **AKT1**  \n    - Central kinase downstream of PI3K; integrates TCR/CD28 and cytokine signals.\n    - KO: impairs survival, metabolism, and effector functions; may promote memory-like features and modulate exhaustion phenotype under chronic TCR + IL‚Äë2.\n\n31. **IL2RG (common Œ≥ chain)**  \n    - Shared component of IL‚Äë2, IL‚Äë7, IL‚Äë15, etc. receptors.\n    - KO: abrogates IL‚Äë2 signaling in both conditions; serves as a maximal perturbation for IL‚Äë2 dependence, clarifies interplay between cytokine and TCR inputs.\n\n32. **STAT5B**  \n    - Key transcription factor downstream of IL‚Äë2R.\n    - KO: diminishes IL‚Äë2 signaling; alters survival/proliferation balance, likely affecting how chronic TCR drives exhaustion vs deletion; highly informative IL‚Äë2‚Äëaxis perturbation.\n\n---\n\n## 5. How these 32 genes maximize perturbation of the phenotype\n\nThis set is crafted to create **large, interpretable shifts** in TCR signaling outputs:\n\n- **Direct exhaustion enforcers (TOX, TOX2, NR4A1/2/3, BATF, IRF4, NFATC1/2, EOMES)**  \n  ‚Üí Their KO should *block or reshape* the exhaustion program, resulting in:\n  - Higher NFAT/NF‚ÄëŒ∫B reporter signal\n  - Lower PD‚Äë1/TIM‚Äë3/TOX expression\n  - Sustained cytokine output in chronic anti‚ÄëCD3 + IL‚Äë2 vs control.\n\n- **Checkpoint receptors & proximal inhibitory machinery (PDCD1, CTLA4, LAG3, HAVCR2, TIGIT, CD244, CD160, CD5, PTPN11, PTPN6, CSK, CBLB, ITCH, SOCS1, CISH)**  \n  ‚Üí Their KO removes **brakes on signaling**, especially evident under chronic stimulation where these brakes are normally engaged. You expect:\n  - Increased TCR signaling amplitude in chronic vs acute\n  - Altered shape of dose‚Äìresponse curves to anti‚ÄëCD3\n  - Possible rescue of function in otherwise exhausted cells.\n\n- **Core TCR/IL‚Äë2 signalosome components (LCP2, LAT, PLCG1, PIK3CD, AKT1, IL2RG, STAT5B)**  \n  ‚Üí Their KO effectively **rewires the input‚Äìoutput relationship**:\n  - Some (LCP2, LAT, PLCG1) collapse TCR signaling: minimal reporter change even under strong anti‚ÄëCD3.\n  - Others (PIK3CD, AKT1) preferentially tune metabolic and survival arms that are critical for chronic responses.\n  - IL2RG and STAT5B mutations decouple IL‚Äë2 effects, revealing which aspects of exhaustion depend on IL‚Äë2‚ÄìSTAT5 vs TCR‚ÄìNFAT.\n\nTogether, you end up with a **diverse, mechanistically rich set of perturbations** that will:\n- Produce large dynamic range in TCR signaling measures.\n- Differentiate modules that regulate **acute activation** vs **chronic exhaustion**.\n- Provide strong positive and negative controls for both TCR and IL‚Äë2 axes.\n\n---\n\n## 6. Practical ‚Äúmini‚Äëscreen‚Äù usage\n\nTo ‚Äúexperience‚Äù the screen with this 32‚Äëgene panel:\n\n1. **Library design**\n   - 3‚Äì4 gRNAs per gene (96‚Äì128 guides total) + 8‚Äì16 non‚Äëtargeting controls and 4‚Äì8 essential gene controls (e.g., RPA3) for QC.\n   - Use SpCas9 KO in primary CD8 T cells or Jurkat + NFAT‚ÄëGFP.\n\n2. **Transduction and selection**\n   - MOI ~0.3 to favor single integration.\n   - Puromycin/blasticidin selection to enrich sgRNA‚Äëpositive cells.\n   - Maintain enough cells for ~500‚Äì1,000√ó coverage per sgRNA if pooled.\n\n3. **Stimulation and readout**\n   - Split cells into:\n     - IL‚Äë2‚Äëonly arm\n     - Anti‚ÄëCD3 + IL‚Äë2 arm (sustained stimulation)\n   - After defined timepoints (e.g., day 3, 7, 14), measure:\n     - NFAT‚ÄëGFP / NF‚ÄëŒ∫B‚ÄëGFP MFI (flow)\n     - PD‚Äë1, TOX, TIM‚Äë3 surface/intracellular staining\n     - Cytokines (IFN‚ÄëŒ≥, TNF, IL‚Äë2) by ELISA/ICS.\n\n4. **Analysis**\n   - For each gene, compute:\n     - ŒîTCR_signal = (chronic condition readout ‚Äì acute condition readout) for KO vs control.\n   - Genes with largest deviation in ŒîTCR_signal (positive or negative) are top regulators of exhaustion vs sustained function.\n\n5. **Follow‚Äëup**\n   - Deep phenotyping (transcriptomics, ATAC‚Äëseq) of the most extreme hits (e.g., TOX‚ÄëKO, NR4A‚Äëtriple KO, PDCD1‚ÄëKO, PTPN11‚ÄëKO, LCP2‚ÄëKO) to delineate pathways.\n\n---\n\nIf you‚Äôd like, I can next:\n- Suggest specific CRISPR sgRNA design strategy for these 32 targets (using the sgRNA Design Guide and CRISPick approach in your environment).\n- Propose concrete readouts (antibody panels, reporter constructs) and a basic analysis pipeline (including statistical comparisons for an arrayed 96‚Äëwell mini‚Äëscreen).  \n</solution>",
            "tool_calls": [],
            "invalid_tool_calls": [],
            "usage_metadata": null,
            "additional_kwargs": {},
            "response_metadata": {}
        }
    ]
}